CA2144973C - Endocardial mapping system - Google Patents
Endocardial mapping system Download PDFInfo
- Publication number
- CA2144973C CA2144973C CA2144973A CA2144973A CA2144973C CA 2144973 C CA2144973 C CA 2144973C CA 2144973 A CA2144973 A CA 2144973A CA 2144973 A CA2144973 A CA 2144973A CA 2144973 C CA2144973 C CA 2144973C
- Authority
- CA
- Canada
- Prior art keywords
- array
- electrode
- heart chamber
- electrical
- dimensional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/282—Holders for multiple electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6858—Catheters with a distal basket, e.g. expandable basket
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3625—External stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3702—Physiological parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
- A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
- A61B2560/045—Modular apparatus with a separable interface unit, e.g. for communication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/043—Arrangements of multiple sensors of the same type in a linear array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
Abstract
A system for mapping electrical activity of a patient's heart includes a set of electrodes (19) spaced from the heart wall (18) and a set of electrodes (24, 26) in contact with the heart wall (18). Voltage measurements from the electrodes are used to generate three-dimensional and two-dimensional maps of the electrical activity of the heart.
Description
ENDOCARDIAL MAPPING SYSTEM
Technical Field The invention discloses the apparatus and technique for forming a three-dimensional electrical map of the interior of a heart chamber, and a related technique for forming a two-dimensional subsurface map at a particular location in the endocardial wall.
Background Art It is common to measure the electrical potentials present on the interior surface of the heart as a part of an electrophysiologic study of a patient's heart.
Typically such measurements are used to form a two-dimensional map of the electrical activity of the heart muscle. An electrophysiologist will use the map to locate centers of ectopic electrical activity occurring within the cardiac tissues. One traditional mapping technique involves a sequence of electrical measurements taken from mobile electrodes inserted into the heart chamber and placed in contact with the surface of the heart. An alternative mapping technique takes essentially simultaneous measurements from a floating electrode array to generate a two-dimensional map of electrical potentials.
The two-dimensional maps of the electrical potentials at the endocardial surface generated by these traditional processes suffer many defects. Traditional systems have been limited in resolution by the number of electrodes used. The number of electrodes dictated the number of points for which the electrical activity of the endocardial surface could be mapped. Therefore, progress in endocardial mapping has involved either the introduction of progressively more electrodes on the mapping catheter or improved flexibility for moving a small mapping probe with electrodes from place to place on the endocardial surface. Direct contact with electrically active tissue is required by most systems in the prior art in order to obtain well conditioned electrical signals. An exception is a non-contact approach with spot electrodes. These spot electrodes spatially average the electrical signal through their conical view of the blood media. This approach therefore also produces one signal for each electrode.
The small number of signals from the endocardial wall will result in the inability to accurately resolve the location of ectopic tissue masses. In the prior art, iso-potentials are interpolated and plotted on a 1o rectilinear map which can only crudely represent the unfolded interior surface of the heart. Such two-dimensional maps are generated by interpolation processes which "fill in" contours based upon a limited set of measurements. Such interpolated two-dimensional maps have significant deficiencies. First, if a localized ectopic focus is between two electrode views such a map will at best show the ectopic focus overlaying both electrodes and all points in between and at worst will not see it at all. Second, the two 2o dimensional map, since it contains no chamber geometry information, cannot indicate precisely where in the three dimensional volume of the heat chamber an electrical signal is located. The inability to accurately characterize the size and location of ectopic tissue frustrates the delivery of certain therapies such as "ablation".
Summary Disclosure In general the present invention provides a method for producing a high-resolution, three-dimensional map of electrical activity of the inside surface of a heart chamber.
The invention uses a specialized catheter system to obtain the information necessary to generate such a map.
In general the invention provides a system and method which permits the location of catheter electrodes to be visualized in the three-dimensional map.
Technical Field The invention discloses the apparatus and technique for forming a three-dimensional electrical map of the interior of a heart chamber, and a related technique for forming a two-dimensional subsurface map at a particular location in the endocardial wall.
Background Art It is common to measure the electrical potentials present on the interior surface of the heart as a part of an electrophysiologic study of a patient's heart.
Typically such measurements are used to form a two-dimensional map of the electrical activity of the heart muscle. An electrophysiologist will use the map to locate centers of ectopic electrical activity occurring within the cardiac tissues. One traditional mapping technique involves a sequence of electrical measurements taken from mobile electrodes inserted into the heart chamber and placed in contact with the surface of the heart. An alternative mapping technique takes essentially simultaneous measurements from a floating electrode array to generate a two-dimensional map of electrical potentials.
The two-dimensional maps of the electrical potentials at the endocardial surface generated by these traditional processes suffer many defects. Traditional systems have been limited in resolution by the number of electrodes used. The number of electrodes dictated the number of points for which the electrical activity of the endocardial surface could be mapped. Therefore, progress in endocardial mapping has involved either the introduction of progressively more electrodes on the mapping catheter or improved flexibility for moving a small mapping probe with electrodes from place to place on the endocardial surface. Direct contact with electrically active tissue is required by most systems in the prior art in order to obtain well conditioned electrical signals. An exception is a non-contact approach with spot electrodes. These spot electrodes spatially average the electrical signal through their conical view of the blood media. This approach therefore also produces one signal for each electrode.
The small number of signals from the endocardial wall will result in the inability to accurately resolve the location of ectopic tissue masses. In the prior art, iso-potentials are interpolated and plotted on a 1o rectilinear map which can only crudely represent the unfolded interior surface of the heart. Such two-dimensional maps are generated by interpolation processes which "fill in" contours based upon a limited set of measurements. Such interpolated two-dimensional maps have significant deficiencies. First, if a localized ectopic focus is between two electrode views such a map will at best show the ectopic focus overlaying both electrodes and all points in between and at worst will not see it at all. Second, the two 2o dimensional map, since it contains no chamber geometry information, cannot indicate precisely where in the three dimensional volume of the heat chamber an electrical signal is located. The inability to accurately characterize the size and location of ectopic tissue frustrates the delivery of certain therapies such as "ablation".
Summary Disclosure In general the present invention provides a method for producing a high-resolution, three-dimensional map of electrical activity of the inside surface of a heart chamber.
The invention uses a specialized catheter system to obtain the information necessary to generate such a map.
In general the invention provides a system and method which permits the location of catheter electrodes to be visualized in the three-dimensional map.
The invention may also be used to provide a two-dimensional map of electrical potential at or below the myocardial tissue surface.
More specifically, the present invention relates to a method of mapping a volumetric electrical potential distribution of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) positioning an electrode array within an endocardial cavity;
b) positioning a'reference electrode at an interior surface of the heart chamber at a known distance from the array, the reference electrode and the array together defining an endocard_Lal reference position;
c) measuring volume and shape of the heart chamber, and generating volume measurernent data from the volume and shape measurements;
d) computing a position of the array, from the volume measurement, and from the end(Dcardial reference position, and generating array position measurement data;
e) measuring electrical potentials on the array, and generating electrical potential measurement data from the electrical potential measurements;
f) computing a three-dimens:ional volumetric electrical field distribution of the heart chamber volume from a spherical harmonic series expression containing the electrical potential measurements, and the array position measurement data; an(I
g) displaying the volumetric electrical field distribution.
The present invention also relates to a method of mapping a two-dimensional electrical potential distribution within a wall of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
3a a) positioning an electrode array within an endocardial cavity;
b) positioning a reference electrode at an interior surface of the heart chamber at a known distance from the array, the reference electrode and the array together defining an endocardial reference position;
c) measuring volume and shape of the heart chamber, and generating volume measurement data from the volume and shape measurements;
d) computing a position of the array, from the volume measurement, and from the endocardial reference position, and generating array position measurement data;
e) measuring electrical potentials on the array, and generating electrical potential measurement data from the electrical potential measurements;
f) computing a three-dimensional volumetric electrical field distribution of the heart chamber volume from a spherical harmoilic series expression containing the electrical potential measurement data, and the array position measurement data;
g) defining a set of computed potential points on the wall of the heart chamber;
h) inserting an intramural electrode into the wall defining a subsurface electro(le site and, generating a subsurface voltage measurement, from the subsurface electrode site;
i) computing a two-dimensional potential distribution from a center of gravity calculation from the computed potential points from step g) and from the subsurface voltage measurement from step h), and generating two-dimensional map data from the two-dimensional potential distribution; and j) displaying a two-dimensional potential distribution map from the two-dimensional map data.
3b The present invention also relates to a use of an electrode array within an endocardial cavity at a known distance from a reference electrode located on an interior surface of a heart chamber, for mapping a volumetric electrical potential distribution of the heart chamber arising from electrical activation in a myocardium, wherein at least a portion of the electrode array is away from contact with the interior surface of the heart chamber.
The present invention also relates to a use of an electrode array within an endocardial cavity at a known distance from a reference electrode located on an interior surface of a heart chamber, for mapping a two-dimensional electrical potential distribution within a wall of the heart chamber arising from electrical activation in a myocardium, wherein at least a portion of the electrode array is away from contact with the interior surface of the heart chamber.
The present invention also relates to a method of mapping a volumetric electrical potential distribution of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential 3c measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurements, and said array position measurement data; and e) displaying said volumetric electrical field distribution.
The present invention also relates to a method of mapping a two-dimensional electrical potential distribution within a wall of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential 3d measurement data, and said array position measurement data;
e) defining a set of computed potential points on the wall of said heart chamber;
f) generating a subsurface voltage measurement from a subsurface electrode site defined by an intramural electrode within said wall;
g) computing a two-dimensional potential distribution from a center of gravity calculation from said computed potential points from step e) and from said subsurface voltage measurement from step f), and generating two-dimensional map data from the two-dimensional potential distribution;
and h) displaying a two-dimensional potential distribution map from said two-dimensional map data.
The present invention also relates to a use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a volumetric electrical potential distribution of the heart chamber arising from electrical activation in a myocardium.
The present invention also relates to a use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a two-dimensional electrical potential distribution -3e-within a wall of the heart chamber arising from electrical activation in a myocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with a catheter located in the heart chamber; b) determining the position of the catheter; and c) creating a three-dimensional representation of the physiological data, wherein the representation is a continuous representation of substantially the whole endocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with a catheter located in the heart chamber; b) determining the position of the catheter; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the catheter superimposed on the representation.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the electrode superimposed on the representation.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; and c) creating a three-dimensional -3f-representation of the physiological data, wherein the representation is a continuous representation of substantially the whole endocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; and c) creating a three-dimensional representation of the physiological data, wherein the representation is a continuous representation of electrical activity of an endocardial surface.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode of a catheter, said electrode being in the heart chamber; b) determining the position of the electrode; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the catheter superimposed on the representation.
The present invention also relates to a system that acquires and represents physiological data in a heart chamber, comprising: a catheter having an electrode positionable in the heart chamber to acquire physiological data; an analog-to-digital converter coupled to the catheter to process catheter position information and the physiological data; and a computer usable medium having computer readable program code to represent the physiological data in the heart chamber, the computer readable program code comprising: code to create a three-dimensional representation of the physiological data using the catheter position information.
-3g-The present invention also relates to a computer usable medium, for use with a system that acquires and represents physiological data in a heart chamber, wherein the system includes a catheter having an electrode positionable in the heart chamber to acquire physiological data and an analog-to-digital converter coupled to the catheter to process catheter position information and the physiological data, the computer usable medium having computer readable program code to cause an application program to execute on a computer to acquire and represent the physiological data in the heart chamber, the computer readable program code comprising: code to create a three-dimensional representation of the physiological data using the catheter position information.
Additional features of the invention will appear from the following description in which the illustrative embodiment is set forth in detail in conjunction with the accompanying drawings. It should be understood that many modifications to the invention, and in particular to the preferred embodiment illustrated in these drawings, may be made without departing from the scope of the invention.
Figure 1 is a schematic view of the system.
Figure 2 is a view of the catheter assembly placed in an endocardial cavity.
Figure 3 is a schematic view of the catheter assembly.
Figure 4 is a view of the mapping catheter with the deformable lead body in the collapsed position.
-3h-Figure 5 is a view of the mapping catheter with the deformable lead body in the expanded position.
Figure 6 is a view of the reference catheter.
Figure 7 is a schematic view representing the display of the three-dimensional map.
Figure 8 is a side view of an alternate reference catheter.
Figure 9 is a side view of an alternate reference catheter.
Figure 10 is a perspective view of an alternate distal tip.
Figure 11 is a schematic view representing the display of the subsurface two-dimensional map.
Figure 12 is a schematic flow chart of the steps in the method.
Detailed Disclosure In general, the system of the present invention is used for mapping the electrical activity of the interior WO 94/06349 a ., . PCT/US93/09015 4 ~
surface of a heart chamber 80. The mapping catheter assembly 14 includes a flexible lead body 72 connected to a deformable distal lead body 74. The deformable distal lead body 74 can be formed into a stable space filling geometric shape after introduction into the heart cavity 80. This deformable distal lead body 74 includes an electrode array 19 defining a number of electrode sites. The mapping catheter assembly 14 also includes a reference electrode preferably placed on a Zo reference catheter 16 which passes through a central lumen 82 formed in the flexible lead body 72 and the distal lead body 74. The reference catheter assembly 16 has a distal tip electrode assembly 24 which may be used to probe the heart wall. This distal contact electrode assembly 24 provides a surface electrical reference for calibration. The physical length of the reference catheter 16-taken with the position of the electrode array 19 together provide a reference which may be used to calibrate the electrode array 19. The reference catheter 16 also stabilizes the position of the electrode array 19 which is desirable.
These structural elements provide a mapping catheter assembly which can be readily positioned within the heart and used to acquire highly accurate information concerning the electrical activity of the heart from a first set of preferably non-contact electrode sites and a second set of in-contact electrode sites.
The mapping catheter assembly 14 is coupled to interface apparatus 22 which contains a signal generator 32, and voltage acquisition apparatus 30. Preferably, in use, the signal generator 32 is used to measure the volumetric shape of the heart chamber through impedance plethysmography. This signal generator is also used to determine the position of the reference electrode within the heart chamber. Other techniques for characterizing the shape of the heart chamber may be substituted.
~ 5 Next, the signals from all the electrode sites on the electrode array 19 are presented to the voltage acquisition apparatus 30 to derive a three-dimensional, = instantaneous high resolution map of the electrical activity of the entire heart chamber volume. This map is calibrated by the use of a surface electrode 24. The calibration is both electrical and dimensional. Lastly this three-dimensional map, along with the signal from an intramural electrode 26 preferably at the tip of the reference catheter 16, is used to compute a two-dimensional map of the intramural electrical activity within the heart wall. The two-dimensional map is a slice of the heart wall and represents the subsurface electrical activity in the heart wall itself.
Both of these "maps" can be followed over time which is desirable. The true three-dimensional map also avoids the problem of spatial averaging and generates an instantaneous, high resolution map of the electrical activity of the entire volume of the heart chamber and the endocardial surface. This three-dimensional map is an order of magnitude more accurate and precise than previously obtained interpolation maps. The two-dimensional map of the intramural slice is unavailable using prior techniques. -Hardware Description Figure 1 shows the mapping system 10 coupled to a patient's heart 12. The mapping catheter assembly 14 is inserted into a heart chamber and the reference electrode 24 touches the endocardial surface 18.
The preferred array catheter 20 carries at least twenty-four individual electrode sites which are coupled to the interface apparatus 22. The preferred reference catheter 16 is a coaxial extension of the array catheter 20. This reference catheter 16 includes a surface electrode site 24 and a subsurface electrode site 26 both of which are coupled to the interface apparatus 22.
It should be understood that the electrode site 24 can be located directly on the array catheter. The array catheter 20 may be expanded into a known geometric shape, preferably spherical. Resolution is enhanced by the use of larger sized spherical shapes. A balloon 77 or the like should be incorporated under the electrode array 19 to exclude blood from the interior of the electrode array 19. The spherical shape and exclusion of blood are not required for operability but they materially reduce the complexity of the calculations required to generate the map displays.
The reference electrode 24 and/or the reference catheter 16 serves several purposes. First they stabilize and maintain the array 19 at a known distance from a reference point on the endocardial surface 18 for calibration of the shape and volume calculations. Secondly, the surface electrode 24 is used to calibrate the electrical activity measurements of the endocardial surface 18 provided by the electrode array 19.
The interface apparatus 22 includes a switching assembly 28 which is a multiplexor to sequentially couple the various electrode sites to the voltage acquisition apparatus 30, and the signal generator apparatus 32. These devices are under the control of a computer 34. The voltage acquisition apparatus 30 is preferably a 12 bit A to D convertor. A signal -generator 32 is also supplied to generate low current pulses for determining the volume and shape of the endocardial chamber using impedance plethysmography, and for determining the location of the reference catheter.
The computer 34 is preferably of the "workstation"
class to provide sufficient processing power to operate in essentially real time. This computer operates under the control of software set forth in the flow charts of Figures 12A and 12B.
~ ~114973 Catheter Description Figure 2 shows a portion of the mapping catheter assembly 14 placed into a heart chamber 80. The mapping catheter assembly 14 includes a reference catheter 16 and an array catheter 20. In Figure 2 the array catheter = 20 has been expanded through the use of a stylet 92 to place the electrode array 19 into a stable and reproducible geometric shape. The reference catheter 16 has been passed through the lumen 82 of the array 1o catheter 20 to place a distal tip electrode assembly 24 into position against an endocardial surface. In use, the reference catheter 16 provides a mechanical location reference for the position of the electrode array 19, and the tip electrode assembly 24 provides an electrical potential reference at or in the heart wall for the mapping process.
Although the structures of Figure 1 are preferred there are several alternatives within the scope of the invention. The principle objective of the preferred form of the catheter system is to reliably place a known collection of electrode sites away from the endocardial surface, and one or more electrode sites into contact with the endocardium. The array catheter is an illustrative structure for placing at least some of the electrode sites away from the endocardial surface. The array catheter itself can be designed to mechanically position one or more electrode sites on the endocardial surface. The reference catheter is a preferred structure for carrying one or more electrode sites and may be used to place these electrode sites into direct contact with the endocardial surface.
It should be understood that the reference catheter could be replaced with a fixed extension of the array catheter and used to push a segment of the array onto the endocardial surface. In this alternate embodiment the geometric shape of the spherical array maintains the other electrodes out of contact with the endocardial WO 94/06349 PCr/US93/09015 surface.
Figure 3 shows the preferred construction of the mapping catheter assembly 14 in exaggerated scale to clarify details of construction. In general, the array catheter 20 includes a flexible lead body 72 coupled to a deformable lead body 74. The deformable lead body 74 is preferably a braid 75 of insulated wires, several of which are shown as wire 93, wire 94, wire 95 and wire 96. An individual wire such as 93 may be traced in the figure from the electrical connection 79 at the proximal end 81 of the flexible lead body 72 through the flexible lead body 72 to the distal braid ring 83 located on the deformable lead body 74. At a predetermined location in the deformable lead body 74 the insulation has been selectively removed from this wire 93 to form a representative electrode site 84. Each of the several wires in the braid 75 may potentially be used to form an electrode site. Preferably all of the typically twenty-four to one-hundred-twenty-eight wires in the braid 75 are used to form electrode sites. Wires not used as electrode sites provide mechanical support for the electrode array 19. In general, the electrode sites will be located equidistant from a center defined at the center of the spherical array. Other geometrical shapes are usable including ellipsoidal and the like.
The proximal end 81 of the mapping catheter assembly 14 has suitable electrical connection 79 for the individual wires connected to the various electrode sites. Similarly the proximal connector 79 can have a suitable electrical connection for the distal tip electrode assembly 24 of the reference catheter 16 or the reference catheter 16 can use a separate connector.
The distance 90 between the electrode array 19 and the distal tip assembly 24 electrode can preferentially be varied by sliding the reference catheter through the lumen 82, as shown by motion arrow 85. This distance 90 may be "read" at the proximal end 81 by noting the ~ 9 relative position of the end of the lead body 72 and the proximal end of the reference catheter 16.
Figure 4 is a view of the mapping catheter with the deformable lead body 74 in the collapsed position.
Figure 5 shows that the wire stylet 92 is attached = to the distal braid ring 83 and positioned in the lumen 82. Traction applied to the distal braid ring 83 by relative motion of the stylet 92 with respect to the lead body 72 causes the braid 75 to change shape. In io general, traction causes the braid 75 to move from a generally cylindrical form seen in Figure 4 to a generally spherical form seen best in Figure 2 and Figure 5.
The preferred technique is to provide a stylet 92 which can be used to pull the braid 75 which will deploy the electrode array 19. However, other techniques may be used as well including an optional balloon 77 shown as in Figure 3, which could be inflated under the electrode array 19 thereby causing the spherical deployment of the array 19. Modification of the braid 75 can be used to control the final shape of the array 19. For example an asymmetrical braid pattern using differing diameter wires within the braid can preferentially alter the shape of the array. The most important property of the geometric shape is that it spaces the electrode sites relatively far apart and that the shape be predictable with a high degree of accuracy.
Figure 6 shows a first embodiment of the reference catheter 16 where the distal electrode assembly 24 is 3o blunt and may be used to make a surface measurement against the endocardial surface. In this version of the catheter assembly the wire 97 (Figure 2) communicates to the distal tip electrode and this wire may be terminated in the connector 79.
Figure 8 shows an alternate reference catheter 98 which is preferred if both surface and/or subsurface measurements of the potential proximate the endocardial L,)L~~ 10 surface are desired. This catheter 98 includes both a reference electrode 24 and an extendable intramural electrode body 100.
Figure 9 illustrates the preferred use of an intramural electrode stylet 101 to retract the sharp intramural electrode body 100 into the reference catheter lead body 102. Motion of the intramural electrode body 100 into the lead body 102 is shown by arrow 103.
Figure 10 shows the location of the intramural electrode site 26 on the electrode body 100. It is desirable to use a relatively small electrode site to permit localization of the intramural electrical activity.
The array catheter 20 may be made by any of a variety of techniques. In one method of manufacture, the braid 75 of insulated wires 93,94,95,96 can be encapsulated into a plastic material to form the flexible lead body 72. This plastic material can be any of various biocompatible compounds with polyurethane being preferred. The encapsulation material for the flexible lead body 72 is selected in part for its ability to be selectively removed to expose the insulated braid 75 to form the deformable lead body 74.
The use of a braid 75 rather than a spiral wrap, axial wrap, or other configuration inherently strengthens and supports the electrodes due to the interlocking nature of the braid. This interlocking braid 75 also insures that, as the electrode array 19 deploys, it does so with predictable dimensional control. This braid 75 structure also supports the array catheter 20 and provides for the structural integrity of the array catheter 20 where the encapsulating material has been removed.
To form the deformable lead body 74 at the distal end of the array catheter 20, the encapsulating material can be removed by known techniques. In a preferred ~ 11 embodiment this removal is accomplished by mechanical removal of the encapsulating material by grinding or the like. It is also possible to remove the material with a solvent. If the encapsulating material is polyurethane, tetrahydrofuran or cyclohexanone can be used as a solvent. In some embodiments the encapsulating material is not removed from the extreme distal tip to provide enhanced mechanical integrity forming a distal braid ring 83.
With the insulated braid 75 exposed, to form the deformable lead body 74 the electrodes sites can be formed by removing the insulation over the conductor in selected areas. Known techniques would involve mechanical, thermal or chemical removal of the insulation followed by identification of the appropriate conducting wire at the proximal connector 79. This method makes it difficult to have the orientation of the proximal conductors in a predictable repeatable manner.
Color coding of the insulation to enable selection of the conductor/electrode is possible but is also difficult when large numbers of electrodes are required.
Therefore it is preferred to select and form the electrode array through the use of high voltage electricity. By applying high voltage electricity (typically 1-3 KV) to the proximal end of the conductor and detecting this energy through the insulation it is possible to facilitate the creation of the electrode on a known conductor at a desired location. After localization, the electrode site can be created by 3o removing insulation using standard means or by applying a higher voltage (eg. 5 KV) to break through the insulation.
Modifications can be made to this mapping catheter assembly without departing from the teachings of the present invention. Accordingly the scope of the invention is only to be limited only by the accompanying claims.
Software Description The illustrative method may be partitioned into nine steps as shown in Figure 12. The partitioning of the step-wise sequence is done as an aid to explaining the invention and other equivalent partitioning can be readily substituted without departing from the scope of the invention.
At step 41 the process begins. The illustrative process assumes that the electrode array assumes a known lo spherical shape within the heart chamber, and that there are at least twenty-four electrodes on the electrode array 19. This preferred method can be readily modified to accommodate unknown and non-reproducible, non-spherical shaped arrays. The location of each of these electrode sites on the array surface is known from the mechanical configuration of the displayed array. A
method of determining the location of the electrode array 19 and the location of the heart chamber walls (cardiac geometry) must be available. This geometry measurement (options include ultrasound or impedance plethysmography) is performed in step 41. If the reference catheter 16 is extended to the chamber wall 18 then its length can be used to calibrate the geometry measurements since the calculated distance can be compared to the reference catheter length. The geometry calculations are forced to converge on the known spacing represented by the physical dimensions of the catheters.
In an alternative embodiment reference electrode 24 is positioned on array catheter 20 and therefore its position would be known.
In step 42 the signals from all the electrode sites in the electrode array 19 are sampled by the A to D
converter in the voltage acquisition apparatus 30.
These measurements are stored in a digital file for later use in following steps. At this point (step 43) the known locations of all the electrodes on the electrode array 19 and the measured potentials at each electrode are used to create the intermediate parameters of the three-dimensional electrical activity map. This step uses field theory calculations presented in greater detail below. The components which are created in this step (0,,) are stored in a digital file for later use in following steps.
At the next stage the question is asked whether the reference catheter 16 is in a calibrating position. In the calibrating position, the reference catheter 16 io projects directly out of the array catheter 20 establishing a length from the electrode array 19 which is a known distance from the wall 18 of the heart chamber. This calibration position may be confirmed using fluoroscopy. If the catheter is not in position then the process moves to step 45, 46 or 47.
If the reference catheter 16 is in the calibrating position then in step 44 the exact position of the reference catheter 16 is determined using the distance and orientation data from step 41. The available information includes position in space of the reference catheter 16 on the chamber wall 18 and the intermediate electrical activity map parameters of the three-dimensional map. Using these two sets of information the expected electrical activity at the reference catheter surface electrode site 24 is determined. The actual potential at this site 24 is measured from the reference catheter by the A to D converter in the voltage acquisition apparatus 30. Finally, a scale factor is adjusted which modifies the map calculations to achieve calibrated results. This adjustment factor is used in all subsequent calculations of electrical activity.
At step 47 the system polls the user to display a three-dimensional map. If such a map is desired then a method of displaying the electrical activity is first determined. Second an area, or volume is defined for which the electrical activity is to be viewed. Third a ~~
level of resolution is defined for this view of the electrical activity. Finally the electrical activity at all of the points defined by the display option, volume and resolution are computed using the field theory calculations and the adjustment factor mentioned above.
These calculated values are then used to display the data on computer 34.
Figure 7 is a representative display 71 of the output of process 47. In the preferred presentation the heart is displayed as a wire grid 36. The iso-potential map for example is overlaid on the wire grid 36 and several iso-potential lines such as iso-potential or isochrone line 38 are shown on the drawing. Typically the color of the wire grid 36 and the iso-potential or isochrone lines will be different to aid interpretation.
The potentials may preferably be presented by a continuously filled color-scale rather than iso-potential or isochrone lines. The tightly closed iso-potential or isochrone line 39 may arise from an ectopic focus present at this location in the heart. In the representative display 71 of process 47 the mapping catheter assembly will notbe shown.
In step 45 a subthreshold pulse is supplied to the surface electrode 24 of the reference catheter 16 by the signal generator 32. In step 54 the voltages are measured at all of the electrode sites on the electrode array 19 by the voltage acquisition apparatus 30. One problem in locating the position of the subthreshold pulse is that other electrical activity may render it difficult to detect. To counteract this problem step 55 starts by subtracting the electrical activity which was just measured in step 44 from the measurements in step 54. The location of the tip of the reference catheter 16 (i.e. surface electrode 24), is found by first performing the same field theory calculations of step 45 on this derived electrode data. Next, four positions in space are defined which are positioned near the heart s ~ 15 chamber walls. The potentials at these sites are calculated using the three-dimensional electrical activity map. These potentials are then used to = triangulate, and thus determine, the position of the subthreshold pulse at the surface electrode 24 of the reference catheter 16. If more accurate localization is desired then four more points which are much closer to the surface electrode 24 can be defined and the triangulation can be performed again. This procedure lo for locating the tip of the reference catheter 16 can be performed whether the surface electrode 24 is touching the surface or is located in the blood volume and is not in contact with the endocardial surface.
At step 48 the reference catheter's position in space can be displayed by superimposing it on the map of electrical activity created in step 47. An example of such a display 71 is presented in Figure 7.
When step 46 is reached the surface electrode 24 is in a known position on the endocardial surface 18 of the heart chamber which is proper for determining the electrical activity of the tissue at that site. If the intramural or subsurface extension 100 which preferentially extends from the tip of the reference catheter 102 is not inserted into the tissue then the user of the system extends the subsurface electrode 26 into the wall 18. The potentials from the surface electrode 24 and from the intramural subsurface 26 electrode are measured by voltage acquisition apparatus 30. Next a line 21 along the heart chamber wall which 3o has the surface electrode 24 at its center is defined by the user of the system. The three-dimensional map parameters from step 43 are then used to compute a number of points along this line including the site of the reference catheter surface electrode 24. These calculations are adjusted to conform to the measured.
value at the reference catheter surface electrode 24.
Next a slice of tissue is defined and bounded by this s line 21 (Figure 7) and the location of the intramural subsurface electrode 26 (Figure 11) and computed positions such as 23 and 25. Subsequently a two-dimensional map 27 of the electrical activity of this slice of tissue is computed using the center of gravity calculations detailed below in the section on algorithm descriptions. Points outside of the boundary of the slice cannot be computed accurately. In step 49 this map 27 of electrical activity within the two-dimensional slice is displayed as illustrated in Figure 11. In this instance the iso-potential line 17 indicates the location within the wall 18 of the ectopic focus.
Description of the Preferred Computing Algorithms Two different algorithms are suitable for implementing different stages of the present invention.
The algorithm used to derive the map of the electrical activity of the heart chamber employs electrostatic volume-conductor field theory to derive a high resolution map of the chamber volume. The second algorithm is able to estimate intramural electrical activity by interpolating between points on the endocardial surface and an intramural measurement using center of gravity calculations.
In use, the preliminary process steps identify the, position of the electrode array 19 consequently the field theory algorithm can be initialized with both contact and non-contact type data. This is one difference from the traditional prior art techniques which require either contact or non-contact for accurate results, but cannot accommodate both. This also permits the system to discern the difference between small regions of electrical activity close to the electrode array 19 from large regions of electrical activity further away from the electrode array 19.
In the first algorithm, from electrostatic volume-conductor field theory it follows that all the ~ 17 electrodes within the solid angle view of every locus of electrical activity on the endocardial surface are integrated together to reconstruct the electrical activity at any given locus throughout the entire volume and upon the endocardium. Thus as best shown in Figure 7 the signals from the electrode array 19 on the catheter 20 produce a continuous map of the whole endocardium. This is another difference between the present method and the traditional prior art approach which use the electrode with the lowest potential as the indicator of cardiac abnormality. By using the complete information in the algorithm, the resolution of the map shown in Figure 7 is improved by at least a factor of ten over prior methods. Other improvements include: the ls ability to find the optimal global minimum instead of sub-optimal local minima; the elimination of blind spots between electrodes; the ability to detect abnormalities caused by multiple ectopic foci; the ability to distinguish between a localized focus of electrical 2o activity at the endocardial surface and a distributed path of electrical activity in the more distant myocardium; and the ability to detect other types of electrical abnormalities including detection of ischemic or infarcted tissue.
25 The algorithm for creating the 3D map of the cardiac volume takes advantage of the fact that myocardial electrical activity instantaneously creates potential fields by electrotonic conduction. Since action potentials propagate several orders of magnitude 3o slower than the speed of electrotonic conduction, the potential field is quasi-static. Since there are no significant charge sources in the blood volume, Laplace's Equation for potential completely describes the potential field in the blood volume:
18 ~
v24)=0 LaPlace's equation can be solved numerically or analytically. Such numerical techniques include boundary element analysis and other interative approaches comprised of estimating sums of nonlinear coefficients.
Specific analytical approaches can be developed based on the shape of the probe (i.e. spherical, prolate io spherical or cylindrical). From electrostatic field theory, the general spherical harmonic series solution for potential is:
1=0 1 E { A1r1+B1r-c1-~~}40j.Yj"'(8,(p) m=-1 In spherical harmonics, Yl.(B,(p) is the spherical harmonic series made up of Legendre Polynomials. O,m is the lma' component of potential and is defined as:
Cm f V(8, (P) Y1.. (A. (P) dn where V(9,(p) is the measured potential over the probe radius R and dS2 is the differential solid angle and, in spherical coordinates, is defined as:
dt2 = s in8 d8 dcp WO 94/06349 21q 4973 PC'I'/US93/09015 ~ `~
During the first step in the algorithmic determination of the 3D map of.the electrical activity each Olm component is determined by integrating the potential at a given point with the spherical harmonic at that point with respect to the solid angle element subtended from the origin to that point. This is an important aspect of the 3D map; its accuracy in creating the 3D map is increased with increased numbers of electrodes in the array and with increased size of the spherical array. In practice it is necessary to compute the ~Djm components with the subscript 1 set to 4 or greater. These 01Q, components are stored in an 1 by m array for later determination of potentials anywhere in the volume within the endocardial walls.
The bracketed expression of equation 1 (in terms of A,, Bõ and r) simply contains the extrapolation coefficients that weight the measured probe components to obtain the potential components anywhere in the cavity. Once again, the weighted components are summed to obtain the actual potentials. Given that the potential is known on the probe boundary, and given that the probe boundary is non-conductive, we can determine the coefficients A1 and Bi, yielding the following final solution for potential at any point within the boundaries of the cavity, using a spherical probe of radius R:
(z.8. 9) = E E [C ~+1/1 Rl1+1 21+1x R1-1-~1 ~~YZm (6, <P) 1=0m=-1 / J
On exemplary method for evaluating the integral for 0,,õ is the technique of Filon integration with an estimating sum, discretized by p latitudinal rows and q longitudinal columns of electrodes on the spherical probe.
WO 94/06349 PCr/US93/09015 4n V(8=. (PJ) YI.",(8S. gj) Pq'1=1 j=1 Note that p times q equals the total number of electrodes on the spherical probe array. The angle 0 ranges from zero to rt radians and cp ranges from zero to 2rr radians.
More specifically, the present invention relates to a method of mapping a volumetric electrical potential distribution of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) positioning an electrode array within an endocardial cavity;
b) positioning a'reference electrode at an interior surface of the heart chamber at a known distance from the array, the reference electrode and the array together defining an endocard_Lal reference position;
c) measuring volume and shape of the heart chamber, and generating volume measurernent data from the volume and shape measurements;
d) computing a position of the array, from the volume measurement, and from the end(Dcardial reference position, and generating array position measurement data;
e) measuring electrical potentials on the array, and generating electrical potential measurement data from the electrical potential measurements;
f) computing a three-dimens:ional volumetric electrical field distribution of the heart chamber volume from a spherical harmonic series expression containing the electrical potential measurements, and the array position measurement data; an(I
g) displaying the volumetric electrical field distribution.
The present invention also relates to a method of mapping a two-dimensional electrical potential distribution within a wall of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
3a a) positioning an electrode array within an endocardial cavity;
b) positioning a reference electrode at an interior surface of the heart chamber at a known distance from the array, the reference electrode and the array together defining an endocardial reference position;
c) measuring volume and shape of the heart chamber, and generating volume measurement data from the volume and shape measurements;
d) computing a position of the array, from the volume measurement, and from the endocardial reference position, and generating array position measurement data;
e) measuring electrical potentials on the array, and generating electrical potential measurement data from the electrical potential measurements;
f) computing a three-dimensional volumetric electrical field distribution of the heart chamber volume from a spherical harmoilic series expression containing the electrical potential measurement data, and the array position measurement data;
g) defining a set of computed potential points on the wall of the heart chamber;
h) inserting an intramural electrode into the wall defining a subsurface electro(le site and, generating a subsurface voltage measurement, from the subsurface electrode site;
i) computing a two-dimensional potential distribution from a center of gravity calculation from the computed potential points from step g) and from the subsurface voltage measurement from step h), and generating two-dimensional map data from the two-dimensional potential distribution; and j) displaying a two-dimensional potential distribution map from the two-dimensional map data.
3b The present invention also relates to a use of an electrode array within an endocardial cavity at a known distance from a reference electrode located on an interior surface of a heart chamber, for mapping a volumetric electrical potential distribution of the heart chamber arising from electrical activation in a myocardium, wherein at least a portion of the electrode array is away from contact with the interior surface of the heart chamber.
The present invention also relates to a use of an electrode array within an endocardial cavity at a known distance from a reference electrode located on an interior surface of a heart chamber, for mapping a two-dimensional electrical potential distribution within a wall of the heart chamber arising from electrical activation in a myocardium, wherein at least a portion of the electrode array is away from contact with the interior surface of the heart chamber.
The present invention also relates to a method of mapping a volumetric electrical potential distribution of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential 3c measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurements, and said array position measurement data; and e) displaying said volumetric electrical field distribution.
The present invention also relates to a method of mapping a two-dimensional electrical potential distribution within a wall of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential 3d measurement data, and said array position measurement data;
e) defining a set of computed potential points on the wall of said heart chamber;
f) generating a subsurface voltage measurement from a subsurface electrode site defined by an intramural electrode within said wall;
g) computing a two-dimensional potential distribution from a center of gravity calculation from said computed potential points from step e) and from said subsurface voltage measurement from step f), and generating two-dimensional map data from the two-dimensional potential distribution;
and h) displaying a two-dimensional potential distribution map from said two-dimensional map data.
The present invention also relates to a use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a volumetric electrical potential distribution of the heart chamber arising from electrical activation in a myocardium.
The present invention also relates to a use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a two-dimensional electrical potential distribution -3e-within a wall of the heart chamber arising from electrical activation in a myocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with a catheter located in the heart chamber; b) determining the position of the catheter; and c) creating a three-dimensional representation of the physiological data, wherein the representation is a continuous representation of substantially the whole endocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with a catheter located in the heart chamber; b) determining the position of the catheter; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the catheter superimposed on the representation.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the electrode superimposed on the representation.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; and c) creating a three-dimensional -3f-representation of the physiological data, wherein the representation is a continuous representation of substantially the whole endocardium.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode located in the heart chamber; b) determining the position of the electrode; and c) creating a three-dimensional representation of the physiological data, wherein the representation is a continuous representation of electrical activity of an endocardial surface.
The present invention also relates to a method of acquiring and representing physiological data in a heart chamber, comprising: a) acquiring physiological data in the heart chamber with an electrode of a catheter, said electrode being in the heart chamber; b) determining the position of the electrode; c) creating a three-dimensional representation of the physiological data; and d) displaying the position of the catheter superimposed on the representation.
The present invention also relates to a system that acquires and represents physiological data in a heart chamber, comprising: a catheter having an electrode positionable in the heart chamber to acquire physiological data; an analog-to-digital converter coupled to the catheter to process catheter position information and the physiological data; and a computer usable medium having computer readable program code to represent the physiological data in the heart chamber, the computer readable program code comprising: code to create a three-dimensional representation of the physiological data using the catheter position information.
-3g-The present invention also relates to a computer usable medium, for use with a system that acquires and represents physiological data in a heart chamber, wherein the system includes a catheter having an electrode positionable in the heart chamber to acquire physiological data and an analog-to-digital converter coupled to the catheter to process catheter position information and the physiological data, the computer usable medium having computer readable program code to cause an application program to execute on a computer to acquire and represent the physiological data in the heart chamber, the computer readable program code comprising: code to create a three-dimensional representation of the physiological data using the catheter position information.
Additional features of the invention will appear from the following description in which the illustrative embodiment is set forth in detail in conjunction with the accompanying drawings. It should be understood that many modifications to the invention, and in particular to the preferred embodiment illustrated in these drawings, may be made without departing from the scope of the invention.
Figure 1 is a schematic view of the system.
Figure 2 is a view of the catheter assembly placed in an endocardial cavity.
Figure 3 is a schematic view of the catheter assembly.
Figure 4 is a view of the mapping catheter with the deformable lead body in the collapsed position.
-3h-Figure 5 is a view of the mapping catheter with the deformable lead body in the expanded position.
Figure 6 is a view of the reference catheter.
Figure 7 is a schematic view representing the display of the three-dimensional map.
Figure 8 is a side view of an alternate reference catheter.
Figure 9 is a side view of an alternate reference catheter.
Figure 10 is a perspective view of an alternate distal tip.
Figure 11 is a schematic view representing the display of the subsurface two-dimensional map.
Figure 12 is a schematic flow chart of the steps in the method.
Detailed Disclosure In general, the system of the present invention is used for mapping the electrical activity of the interior WO 94/06349 a ., . PCT/US93/09015 4 ~
surface of a heart chamber 80. The mapping catheter assembly 14 includes a flexible lead body 72 connected to a deformable distal lead body 74. The deformable distal lead body 74 can be formed into a stable space filling geometric shape after introduction into the heart cavity 80. This deformable distal lead body 74 includes an electrode array 19 defining a number of electrode sites. The mapping catheter assembly 14 also includes a reference electrode preferably placed on a Zo reference catheter 16 which passes through a central lumen 82 formed in the flexible lead body 72 and the distal lead body 74. The reference catheter assembly 16 has a distal tip electrode assembly 24 which may be used to probe the heart wall. This distal contact electrode assembly 24 provides a surface electrical reference for calibration. The physical length of the reference catheter 16-taken with the position of the electrode array 19 together provide a reference which may be used to calibrate the electrode array 19. The reference catheter 16 also stabilizes the position of the electrode array 19 which is desirable.
These structural elements provide a mapping catheter assembly which can be readily positioned within the heart and used to acquire highly accurate information concerning the electrical activity of the heart from a first set of preferably non-contact electrode sites and a second set of in-contact electrode sites.
The mapping catheter assembly 14 is coupled to interface apparatus 22 which contains a signal generator 32, and voltage acquisition apparatus 30. Preferably, in use, the signal generator 32 is used to measure the volumetric shape of the heart chamber through impedance plethysmography. This signal generator is also used to determine the position of the reference electrode within the heart chamber. Other techniques for characterizing the shape of the heart chamber may be substituted.
~ 5 Next, the signals from all the electrode sites on the electrode array 19 are presented to the voltage acquisition apparatus 30 to derive a three-dimensional, = instantaneous high resolution map of the electrical activity of the entire heart chamber volume. This map is calibrated by the use of a surface electrode 24. The calibration is both electrical and dimensional. Lastly this three-dimensional map, along with the signal from an intramural electrode 26 preferably at the tip of the reference catheter 16, is used to compute a two-dimensional map of the intramural electrical activity within the heart wall. The two-dimensional map is a slice of the heart wall and represents the subsurface electrical activity in the heart wall itself.
Both of these "maps" can be followed over time which is desirable. The true three-dimensional map also avoids the problem of spatial averaging and generates an instantaneous, high resolution map of the electrical activity of the entire volume of the heart chamber and the endocardial surface. This three-dimensional map is an order of magnitude more accurate and precise than previously obtained interpolation maps. The two-dimensional map of the intramural slice is unavailable using prior techniques. -Hardware Description Figure 1 shows the mapping system 10 coupled to a patient's heart 12. The mapping catheter assembly 14 is inserted into a heart chamber and the reference electrode 24 touches the endocardial surface 18.
The preferred array catheter 20 carries at least twenty-four individual electrode sites which are coupled to the interface apparatus 22. The preferred reference catheter 16 is a coaxial extension of the array catheter 20. This reference catheter 16 includes a surface electrode site 24 and a subsurface electrode site 26 both of which are coupled to the interface apparatus 22.
It should be understood that the electrode site 24 can be located directly on the array catheter. The array catheter 20 may be expanded into a known geometric shape, preferably spherical. Resolution is enhanced by the use of larger sized spherical shapes. A balloon 77 or the like should be incorporated under the electrode array 19 to exclude blood from the interior of the electrode array 19. The spherical shape and exclusion of blood are not required for operability but they materially reduce the complexity of the calculations required to generate the map displays.
The reference electrode 24 and/or the reference catheter 16 serves several purposes. First they stabilize and maintain the array 19 at a known distance from a reference point on the endocardial surface 18 for calibration of the shape and volume calculations. Secondly, the surface electrode 24 is used to calibrate the electrical activity measurements of the endocardial surface 18 provided by the electrode array 19.
The interface apparatus 22 includes a switching assembly 28 which is a multiplexor to sequentially couple the various electrode sites to the voltage acquisition apparatus 30, and the signal generator apparatus 32. These devices are under the control of a computer 34. The voltage acquisition apparatus 30 is preferably a 12 bit A to D convertor. A signal -generator 32 is also supplied to generate low current pulses for determining the volume and shape of the endocardial chamber using impedance plethysmography, and for determining the location of the reference catheter.
The computer 34 is preferably of the "workstation"
class to provide sufficient processing power to operate in essentially real time. This computer operates under the control of software set forth in the flow charts of Figures 12A and 12B.
~ ~114973 Catheter Description Figure 2 shows a portion of the mapping catheter assembly 14 placed into a heart chamber 80. The mapping catheter assembly 14 includes a reference catheter 16 and an array catheter 20. In Figure 2 the array catheter = 20 has been expanded through the use of a stylet 92 to place the electrode array 19 into a stable and reproducible geometric shape. The reference catheter 16 has been passed through the lumen 82 of the array 1o catheter 20 to place a distal tip electrode assembly 24 into position against an endocardial surface. In use, the reference catheter 16 provides a mechanical location reference for the position of the electrode array 19, and the tip electrode assembly 24 provides an electrical potential reference at or in the heart wall for the mapping process.
Although the structures of Figure 1 are preferred there are several alternatives within the scope of the invention. The principle objective of the preferred form of the catheter system is to reliably place a known collection of electrode sites away from the endocardial surface, and one or more electrode sites into contact with the endocardium. The array catheter is an illustrative structure for placing at least some of the electrode sites away from the endocardial surface. The array catheter itself can be designed to mechanically position one or more electrode sites on the endocardial surface. The reference catheter is a preferred structure for carrying one or more electrode sites and may be used to place these electrode sites into direct contact with the endocardial surface.
It should be understood that the reference catheter could be replaced with a fixed extension of the array catheter and used to push a segment of the array onto the endocardial surface. In this alternate embodiment the geometric shape of the spherical array maintains the other electrodes out of contact with the endocardial WO 94/06349 PCr/US93/09015 surface.
Figure 3 shows the preferred construction of the mapping catheter assembly 14 in exaggerated scale to clarify details of construction. In general, the array catheter 20 includes a flexible lead body 72 coupled to a deformable lead body 74. The deformable lead body 74 is preferably a braid 75 of insulated wires, several of which are shown as wire 93, wire 94, wire 95 and wire 96. An individual wire such as 93 may be traced in the figure from the electrical connection 79 at the proximal end 81 of the flexible lead body 72 through the flexible lead body 72 to the distal braid ring 83 located on the deformable lead body 74. At a predetermined location in the deformable lead body 74 the insulation has been selectively removed from this wire 93 to form a representative electrode site 84. Each of the several wires in the braid 75 may potentially be used to form an electrode site. Preferably all of the typically twenty-four to one-hundred-twenty-eight wires in the braid 75 are used to form electrode sites. Wires not used as electrode sites provide mechanical support for the electrode array 19. In general, the electrode sites will be located equidistant from a center defined at the center of the spherical array. Other geometrical shapes are usable including ellipsoidal and the like.
The proximal end 81 of the mapping catheter assembly 14 has suitable electrical connection 79 for the individual wires connected to the various electrode sites. Similarly the proximal connector 79 can have a suitable electrical connection for the distal tip electrode assembly 24 of the reference catheter 16 or the reference catheter 16 can use a separate connector.
The distance 90 between the electrode array 19 and the distal tip assembly 24 electrode can preferentially be varied by sliding the reference catheter through the lumen 82, as shown by motion arrow 85. This distance 90 may be "read" at the proximal end 81 by noting the ~ 9 relative position of the end of the lead body 72 and the proximal end of the reference catheter 16.
Figure 4 is a view of the mapping catheter with the deformable lead body 74 in the collapsed position.
Figure 5 shows that the wire stylet 92 is attached = to the distal braid ring 83 and positioned in the lumen 82. Traction applied to the distal braid ring 83 by relative motion of the stylet 92 with respect to the lead body 72 causes the braid 75 to change shape. In io general, traction causes the braid 75 to move from a generally cylindrical form seen in Figure 4 to a generally spherical form seen best in Figure 2 and Figure 5.
The preferred technique is to provide a stylet 92 which can be used to pull the braid 75 which will deploy the electrode array 19. However, other techniques may be used as well including an optional balloon 77 shown as in Figure 3, which could be inflated under the electrode array 19 thereby causing the spherical deployment of the array 19. Modification of the braid 75 can be used to control the final shape of the array 19. For example an asymmetrical braid pattern using differing diameter wires within the braid can preferentially alter the shape of the array. The most important property of the geometric shape is that it spaces the electrode sites relatively far apart and that the shape be predictable with a high degree of accuracy.
Figure 6 shows a first embodiment of the reference catheter 16 where the distal electrode assembly 24 is 3o blunt and may be used to make a surface measurement against the endocardial surface. In this version of the catheter assembly the wire 97 (Figure 2) communicates to the distal tip electrode and this wire may be terminated in the connector 79.
Figure 8 shows an alternate reference catheter 98 which is preferred if both surface and/or subsurface measurements of the potential proximate the endocardial L,)L~~ 10 surface are desired. This catheter 98 includes both a reference electrode 24 and an extendable intramural electrode body 100.
Figure 9 illustrates the preferred use of an intramural electrode stylet 101 to retract the sharp intramural electrode body 100 into the reference catheter lead body 102. Motion of the intramural electrode body 100 into the lead body 102 is shown by arrow 103.
Figure 10 shows the location of the intramural electrode site 26 on the electrode body 100. It is desirable to use a relatively small electrode site to permit localization of the intramural electrical activity.
The array catheter 20 may be made by any of a variety of techniques. In one method of manufacture, the braid 75 of insulated wires 93,94,95,96 can be encapsulated into a plastic material to form the flexible lead body 72. This plastic material can be any of various biocompatible compounds with polyurethane being preferred. The encapsulation material for the flexible lead body 72 is selected in part for its ability to be selectively removed to expose the insulated braid 75 to form the deformable lead body 74.
The use of a braid 75 rather than a spiral wrap, axial wrap, or other configuration inherently strengthens and supports the electrodes due to the interlocking nature of the braid. This interlocking braid 75 also insures that, as the electrode array 19 deploys, it does so with predictable dimensional control. This braid 75 structure also supports the array catheter 20 and provides for the structural integrity of the array catheter 20 where the encapsulating material has been removed.
To form the deformable lead body 74 at the distal end of the array catheter 20, the encapsulating material can be removed by known techniques. In a preferred ~ 11 embodiment this removal is accomplished by mechanical removal of the encapsulating material by grinding or the like. It is also possible to remove the material with a solvent. If the encapsulating material is polyurethane, tetrahydrofuran or cyclohexanone can be used as a solvent. In some embodiments the encapsulating material is not removed from the extreme distal tip to provide enhanced mechanical integrity forming a distal braid ring 83.
With the insulated braid 75 exposed, to form the deformable lead body 74 the electrodes sites can be formed by removing the insulation over the conductor in selected areas. Known techniques would involve mechanical, thermal or chemical removal of the insulation followed by identification of the appropriate conducting wire at the proximal connector 79. This method makes it difficult to have the orientation of the proximal conductors in a predictable repeatable manner.
Color coding of the insulation to enable selection of the conductor/electrode is possible but is also difficult when large numbers of electrodes are required.
Therefore it is preferred to select and form the electrode array through the use of high voltage electricity. By applying high voltage electricity (typically 1-3 KV) to the proximal end of the conductor and detecting this energy through the insulation it is possible to facilitate the creation of the electrode on a known conductor at a desired location. After localization, the electrode site can be created by 3o removing insulation using standard means or by applying a higher voltage (eg. 5 KV) to break through the insulation.
Modifications can be made to this mapping catheter assembly without departing from the teachings of the present invention. Accordingly the scope of the invention is only to be limited only by the accompanying claims.
Software Description The illustrative method may be partitioned into nine steps as shown in Figure 12. The partitioning of the step-wise sequence is done as an aid to explaining the invention and other equivalent partitioning can be readily substituted without departing from the scope of the invention.
At step 41 the process begins. The illustrative process assumes that the electrode array assumes a known lo spherical shape within the heart chamber, and that there are at least twenty-four electrodes on the electrode array 19. This preferred method can be readily modified to accommodate unknown and non-reproducible, non-spherical shaped arrays. The location of each of these electrode sites on the array surface is known from the mechanical configuration of the displayed array. A
method of determining the location of the electrode array 19 and the location of the heart chamber walls (cardiac geometry) must be available. This geometry measurement (options include ultrasound or impedance plethysmography) is performed in step 41. If the reference catheter 16 is extended to the chamber wall 18 then its length can be used to calibrate the geometry measurements since the calculated distance can be compared to the reference catheter length. The geometry calculations are forced to converge on the known spacing represented by the physical dimensions of the catheters.
In an alternative embodiment reference electrode 24 is positioned on array catheter 20 and therefore its position would be known.
In step 42 the signals from all the electrode sites in the electrode array 19 are sampled by the A to D
converter in the voltage acquisition apparatus 30.
These measurements are stored in a digital file for later use in following steps. At this point (step 43) the known locations of all the electrodes on the electrode array 19 and the measured potentials at each electrode are used to create the intermediate parameters of the three-dimensional electrical activity map. This step uses field theory calculations presented in greater detail below. The components which are created in this step (0,,) are stored in a digital file for later use in following steps.
At the next stage the question is asked whether the reference catheter 16 is in a calibrating position. In the calibrating position, the reference catheter 16 io projects directly out of the array catheter 20 establishing a length from the electrode array 19 which is a known distance from the wall 18 of the heart chamber. This calibration position may be confirmed using fluoroscopy. If the catheter is not in position then the process moves to step 45, 46 or 47.
If the reference catheter 16 is in the calibrating position then in step 44 the exact position of the reference catheter 16 is determined using the distance and orientation data from step 41. The available information includes position in space of the reference catheter 16 on the chamber wall 18 and the intermediate electrical activity map parameters of the three-dimensional map. Using these two sets of information the expected electrical activity at the reference catheter surface electrode site 24 is determined. The actual potential at this site 24 is measured from the reference catheter by the A to D converter in the voltage acquisition apparatus 30. Finally, a scale factor is adjusted which modifies the map calculations to achieve calibrated results. This adjustment factor is used in all subsequent calculations of electrical activity.
At step 47 the system polls the user to display a three-dimensional map. If such a map is desired then a method of displaying the electrical activity is first determined. Second an area, or volume is defined for which the electrical activity is to be viewed. Third a ~~
level of resolution is defined for this view of the electrical activity. Finally the electrical activity at all of the points defined by the display option, volume and resolution are computed using the field theory calculations and the adjustment factor mentioned above.
These calculated values are then used to display the data on computer 34.
Figure 7 is a representative display 71 of the output of process 47. In the preferred presentation the heart is displayed as a wire grid 36. The iso-potential map for example is overlaid on the wire grid 36 and several iso-potential lines such as iso-potential or isochrone line 38 are shown on the drawing. Typically the color of the wire grid 36 and the iso-potential or isochrone lines will be different to aid interpretation.
The potentials may preferably be presented by a continuously filled color-scale rather than iso-potential or isochrone lines. The tightly closed iso-potential or isochrone line 39 may arise from an ectopic focus present at this location in the heart. In the representative display 71 of process 47 the mapping catheter assembly will notbe shown.
In step 45 a subthreshold pulse is supplied to the surface electrode 24 of the reference catheter 16 by the signal generator 32. In step 54 the voltages are measured at all of the electrode sites on the electrode array 19 by the voltage acquisition apparatus 30. One problem in locating the position of the subthreshold pulse is that other electrical activity may render it difficult to detect. To counteract this problem step 55 starts by subtracting the electrical activity which was just measured in step 44 from the measurements in step 54. The location of the tip of the reference catheter 16 (i.e. surface electrode 24), is found by first performing the same field theory calculations of step 45 on this derived electrode data. Next, four positions in space are defined which are positioned near the heart s ~ 15 chamber walls. The potentials at these sites are calculated using the three-dimensional electrical activity map. These potentials are then used to = triangulate, and thus determine, the position of the subthreshold pulse at the surface electrode 24 of the reference catheter 16. If more accurate localization is desired then four more points which are much closer to the surface electrode 24 can be defined and the triangulation can be performed again. This procedure lo for locating the tip of the reference catheter 16 can be performed whether the surface electrode 24 is touching the surface or is located in the blood volume and is not in contact with the endocardial surface.
At step 48 the reference catheter's position in space can be displayed by superimposing it on the map of electrical activity created in step 47. An example of such a display 71 is presented in Figure 7.
When step 46 is reached the surface electrode 24 is in a known position on the endocardial surface 18 of the heart chamber which is proper for determining the electrical activity of the tissue at that site. If the intramural or subsurface extension 100 which preferentially extends from the tip of the reference catheter 102 is not inserted into the tissue then the user of the system extends the subsurface electrode 26 into the wall 18. The potentials from the surface electrode 24 and from the intramural subsurface 26 electrode are measured by voltage acquisition apparatus 30. Next a line 21 along the heart chamber wall which 3o has the surface electrode 24 at its center is defined by the user of the system. The three-dimensional map parameters from step 43 are then used to compute a number of points along this line including the site of the reference catheter surface electrode 24. These calculations are adjusted to conform to the measured.
value at the reference catheter surface electrode 24.
Next a slice of tissue is defined and bounded by this s line 21 (Figure 7) and the location of the intramural subsurface electrode 26 (Figure 11) and computed positions such as 23 and 25. Subsequently a two-dimensional map 27 of the electrical activity of this slice of tissue is computed using the center of gravity calculations detailed below in the section on algorithm descriptions. Points outside of the boundary of the slice cannot be computed accurately. In step 49 this map 27 of electrical activity within the two-dimensional slice is displayed as illustrated in Figure 11. In this instance the iso-potential line 17 indicates the location within the wall 18 of the ectopic focus.
Description of the Preferred Computing Algorithms Two different algorithms are suitable for implementing different stages of the present invention.
The algorithm used to derive the map of the electrical activity of the heart chamber employs electrostatic volume-conductor field theory to derive a high resolution map of the chamber volume. The second algorithm is able to estimate intramural electrical activity by interpolating between points on the endocardial surface and an intramural measurement using center of gravity calculations.
In use, the preliminary process steps identify the, position of the electrode array 19 consequently the field theory algorithm can be initialized with both contact and non-contact type data. This is one difference from the traditional prior art techniques which require either contact or non-contact for accurate results, but cannot accommodate both. This also permits the system to discern the difference between small regions of electrical activity close to the electrode array 19 from large regions of electrical activity further away from the electrode array 19.
In the first algorithm, from electrostatic volume-conductor field theory it follows that all the ~ 17 electrodes within the solid angle view of every locus of electrical activity on the endocardial surface are integrated together to reconstruct the electrical activity at any given locus throughout the entire volume and upon the endocardium. Thus as best shown in Figure 7 the signals from the electrode array 19 on the catheter 20 produce a continuous map of the whole endocardium. This is another difference between the present method and the traditional prior art approach which use the electrode with the lowest potential as the indicator of cardiac abnormality. By using the complete information in the algorithm, the resolution of the map shown in Figure 7 is improved by at least a factor of ten over prior methods. Other improvements include: the ls ability to find the optimal global minimum instead of sub-optimal local minima; the elimination of blind spots between electrodes; the ability to detect abnormalities caused by multiple ectopic foci; the ability to distinguish between a localized focus of electrical 2o activity at the endocardial surface and a distributed path of electrical activity in the more distant myocardium; and the ability to detect other types of electrical abnormalities including detection of ischemic or infarcted tissue.
25 The algorithm for creating the 3D map of the cardiac volume takes advantage of the fact that myocardial electrical activity instantaneously creates potential fields by electrotonic conduction. Since action potentials propagate several orders of magnitude 3o slower than the speed of electrotonic conduction, the potential field is quasi-static. Since there are no significant charge sources in the blood volume, Laplace's Equation for potential completely describes the potential field in the blood volume:
18 ~
v24)=0 LaPlace's equation can be solved numerically or analytically. Such numerical techniques include boundary element analysis and other interative approaches comprised of estimating sums of nonlinear coefficients.
Specific analytical approaches can be developed based on the shape of the probe (i.e. spherical, prolate io spherical or cylindrical). From electrostatic field theory, the general spherical harmonic series solution for potential is:
1=0 1 E { A1r1+B1r-c1-~~}40j.Yj"'(8,(p) m=-1 In spherical harmonics, Yl.(B,(p) is the spherical harmonic series made up of Legendre Polynomials. O,m is the lma' component of potential and is defined as:
Cm f V(8, (P) Y1.. (A. (P) dn where V(9,(p) is the measured potential over the probe radius R and dS2 is the differential solid angle and, in spherical coordinates, is defined as:
dt2 = s in8 d8 dcp WO 94/06349 21q 4973 PC'I'/US93/09015 ~ `~
During the first step in the algorithmic determination of the 3D map of.the electrical activity each Olm component is determined by integrating the potential at a given point with the spherical harmonic at that point with respect to the solid angle element subtended from the origin to that point. This is an important aspect of the 3D map; its accuracy in creating the 3D map is increased with increased numbers of electrodes in the array and with increased size of the spherical array. In practice it is necessary to compute the ~Djm components with the subscript 1 set to 4 or greater. These 01Q, components are stored in an 1 by m array for later determination of potentials anywhere in the volume within the endocardial walls.
The bracketed expression of equation 1 (in terms of A,, Bõ and r) simply contains the extrapolation coefficients that weight the measured probe components to obtain the potential components anywhere in the cavity. Once again, the weighted components are summed to obtain the actual potentials. Given that the potential is known on the probe boundary, and given that the probe boundary is non-conductive, we can determine the coefficients A1 and Bi, yielding the following final solution for potential at any point within the boundaries of the cavity, using a spherical probe of radius R:
(z.8. 9) = E E [C ~+1/1 Rl1+1 21+1x R1-1-~1 ~~YZm (6, <P) 1=0m=-1 / J
On exemplary method for evaluating the integral for 0,,õ is the technique of Filon integration with an estimating sum, discretized by p latitudinal rows and q longitudinal columns of electrodes on the spherical probe.
WO 94/06349 PCr/US93/09015 4n V(8=. (PJ) YI.",(8S. gj) Pq'1=1 j=1 Note that p times q equals the total number of electrodes on the spherical probe array. The angle 0 ranges from zero to rt radians and cp ranges from zero to 2rr radians.
5 At this point the determination of the geometry of the endocardial walls enters into the algorithm. The potential of each point on the endocardial wall can now be computed by defining them as r, 0, and V. During the activation sequence the graphical representation of the 1o electrical activity on the endocardial surface can be slowed down by 30 to 40 times to present a picture of the ventricular cavity within a time frame useful for human viewing.
A geometric description of the heart structure is 15 required in order for the algorithm to account for the inherent effect of spatial averaging within the medium (blood). Spatial averaging is a function of both the conductive nature of the medium as well as the physical dimensions of the medium.
20 Given the above computed three-dimensional endocardial potential map, the intramural activation map of Figure 11 is estimated by interpolating between the accurately computed endocardial potentials at locations 23 and 25 (Figure 7), and actual recorded endocardial value at the surface electrode 24 and an actual recorded intramural value at the subsurface electrode 26 site.
This first-order estimation of the myocardial activation map assumes that the medium is homogenous and that the medium contains no charge sources. This myocardial 3o activation estimation is limited by the fact that the myocardial medium is not homogeneous and that there are charge sources contained within the myocardial medium.
If more than one intramural point was sampled the WO 94/06349 214973 PC'r/US93/09015 ~
underlying map of intramural electrical activity could be improved by interpolating between the endocardial surface values and all the sample intramural values.
The center-of-gravity calculations can be summarized by the equation:
n _ 7, F V
( ( rx - i l _k) =1 V(Sx) _ i n _ - r _ l -k ~ ~~x i=1 where, V(,) represents the potential at any desired point defined by the three-dimensional vector x and, V;
represents each of n known potentials at a point defined by the three-dimensional vector ; and, k is an exponent that matches the physical behavior of the tissue medium.
From the foregoing description, it will be apparent that the method for determining a continuous map of the electrical activity of the endocardial surface of the present invention has a number of advantages, some of which have been described above and others of which are inherent in the invention. Also modifications can be made to the mapping probe without departing from the teachings of the present invention. Accordingly the scope of the invention is only to be limited as -necessitated by the accompanying claims.
A geometric description of the heart structure is 15 required in order for the algorithm to account for the inherent effect of spatial averaging within the medium (blood). Spatial averaging is a function of both the conductive nature of the medium as well as the physical dimensions of the medium.
20 Given the above computed three-dimensional endocardial potential map, the intramural activation map of Figure 11 is estimated by interpolating between the accurately computed endocardial potentials at locations 23 and 25 (Figure 7), and actual recorded endocardial value at the surface electrode 24 and an actual recorded intramural value at the subsurface electrode 26 site.
This first-order estimation of the myocardial activation map assumes that the medium is homogenous and that the medium contains no charge sources. This myocardial 3o activation estimation is limited by the fact that the myocardial medium is not homogeneous and that there are charge sources contained within the myocardial medium.
If more than one intramural point was sampled the WO 94/06349 214973 PC'r/US93/09015 ~
underlying map of intramural electrical activity could be improved by interpolating between the endocardial surface values and all the sample intramural values.
The center-of-gravity calculations can be summarized by the equation:
n _ 7, F V
( ( rx - i l _k) =1 V(Sx) _ i n _ - r _ l -k ~ ~~x i=1 where, V(,) represents the potential at any desired point defined by the three-dimensional vector x and, V;
represents each of n known potentials at a point defined by the three-dimensional vector ; and, k is an exponent that matches the physical behavior of the tissue medium.
From the foregoing description, it will be apparent that the method for determining a continuous map of the electrical activity of the endocardial surface of the present invention has a number of advantages, some of which have been described above and others of which are inherent in the invention. Also modifications can be made to the mapping probe without departing from the teachings of the present invention. Accordingly the scope of the invention is only to be limited as -necessitated by the accompanying claims.
Claims (7)
1. A method of mapping a volumetric electrical potential distribution of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurements, and said array position measurement data; and e) displaying said volumetric electrical field distribution.
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurements, and said array position measurement data; and e) displaying said volumetric electrical field distribution.
2. A method of mapping a two-dimensional electrical potential distribution within a wall of a heart chamber arising from electrical activation in a myocardium comprising the steps of:
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurement data, and said array position measurement data;
e) defining a set of computed potential points on the wall of said heart chamber;
f) generating a subsurface voltage measurement from a subsurface electrode site defined by an intramural electrode within said wall;
g) computing a two-dimensional potential distribution from a center of gravity calculation from said computed potential points from step e) and from said subsurface voltage measurement from step f), and generating two-dimensional map data from the two-dimensional potential distribution; and h) displaying a two-dimensional potential distribution map from said two-dimensional map data.
a) measuring volume and shape of said heart chamber, and generating volume measurement data from the volume and shape measurements;
b) computing a position of an electrode array within an endocardial cavity, from said volume measurement, and from an endocardial reference position defined by said array and a reference electrode at an interior surface of said heart chamber at a known distance from said array, and generating array position measurement data;
c) measuring electrical potentials on said array, and generating electrical potential measurement data from the electrical potential measurements;
d) computing a three-dimensional volumetric electrical field distribution of said heart chamber volume from a spherical harmonic series expression containing said electrical potential measurement data, and said array position measurement data;
e) defining a set of computed potential points on the wall of said heart chamber;
f) generating a subsurface voltage measurement from a subsurface electrode site defined by an intramural electrode within said wall;
g) computing a two-dimensional potential distribution from a center of gravity calculation from said computed potential points from step e) and from said subsurface voltage measurement from step f), and generating two-dimensional map data from the two-dimensional potential distribution; and h) displaying a two-dimensional potential distribution map from said two-dimensional map data.
3. The method of claim 1 or 2, wherein said electrode array comprises at least twenty electrodes.
4. The method of claim 1 or 2, wherein said step a) comprises:
a1) generating a sequence of impedance plethysmography signals on said array;
a2) measuring a resultant sequence of plethysmography signals characterizing said heart volume; and a3) generating said volume measurement data from step a2.
a1) generating a sequence of impedance plethysmography signals on said array;
a2) measuring a resultant sequence of plethysmography signals characterizing said heart volume; and a3) generating said volume measurement data from step a2.
5. Use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a volumetric electrical potential distribution of the heart chamber arising from electrical activation in a myocardium.
6. Use of an electrode array within an endocardial cavity and having at least a portion thereof away from contact with an interior surface of a heart chamber, at a known distance from a reference electrode located on an interior surface of the heart chamber, for mapping a two-dimensional electrical potential distribution within a wall of the heart chamber arising from electrical activation in a myocardium.
7. The use of claim 5 or 6, wherein the electrode array comprises at least twenty electrodes.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002678625A CA2678625A1 (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
CA2447239A CA2447239C (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/949,690 US5311866A (en) | 1992-09-23 | 1992-09-23 | Heart mapping catheter |
US07/950,448 | 1992-09-23 | ||
US07/950,448 US5297549A (en) | 1992-09-23 | 1992-09-23 | Endocardial mapping system |
US07/949,690 | 1992-09-23 | ||
PCT/US1993/009015 WO1994006349A1 (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2447239A Division CA2447239C (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
CA002678625A Division CA2678625A1 (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2144973A1 CA2144973A1 (en) | 1994-03-31 |
CA2144973C true CA2144973C (en) | 2010-02-09 |
Family
ID=27130293
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002678625A Pending CA2678625A1 (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
CA2447239A Expired - Lifetime CA2447239C (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
CA2144973A Expired - Lifetime CA2144973C (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002678625A Pending CA2678625A1 (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
CA2447239A Expired - Lifetime CA2447239C (en) | 1992-09-23 | 1993-09-23 | Endocardial mapping system |
Country Status (7)
Country | Link |
---|---|
US (11) | US6826420B1 (en) |
EP (1) | EP0661948B1 (en) |
JP (2) | JP3581888B2 (en) |
AT (1) | ATE160273T1 (en) |
CA (3) | CA2678625A1 (en) |
DE (1) | DE69315354T2 (en) |
WO (1) | WO1994006349A1 (en) |
Families Citing this family (325)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5699796A (en) * | 1993-01-29 | 1997-12-23 | Cardima, Inc. | High resolution intravascular signal detection |
US7189208B1 (en) * | 1992-09-23 | 2007-03-13 | Endocardial Solutions, Inc. | Method for measuring heart electrophysiology |
CA2678625A1 (en) * | 1992-09-23 | 1994-03-31 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Endocardial mapping system |
US7930012B2 (en) | 1992-09-23 | 2011-04-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Chamber location method |
PT681451E (en) * | 1993-01-29 | 2002-02-28 | Medtronic Inc | MULTIPLE DEVICES OF INTRAVASCULAR DETECTION OF ELECTRICAL ACTIVITY |
US5706809A (en) * | 1993-01-29 | 1998-01-13 | Cardima, Inc. | Method and system for using multiple intravascular sensing devices to detect electrical activity |
US5645082A (en) * | 1993-01-29 | 1997-07-08 | Cardima, Inc. | Intravascular method and system for treating arrhythmia |
US6522905B2 (en) | 1993-03-11 | 2003-02-18 | Jawahar M. Desai | Apparatus and method for cardiac ablation |
US5657755A (en) * | 1993-03-11 | 1997-08-19 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
US5433198A (en) | 1993-03-11 | 1995-07-18 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
IL116699A (en) | 1996-01-08 | 2001-09-13 | Biosense Ltd | Method of constructing cardiac map |
AU7924694A (en) * | 1993-10-01 | 1995-05-01 | Target Therapeutics, Inc. | Sheathed multipolar catheter and multipolar guidewire for sensing cardiac electrical activity |
US6690963B2 (en) | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
CA2197065A1 (en) * | 1995-04-20 | 1996-10-24 | Jawahar M. Desai | Apparatus for cardiac ablation |
AU697414B2 (en) * | 1995-04-20 | 1998-10-08 | Jawahar M. Desai | Apparatus for cardiac mapping and ablation |
US5718241A (en) * | 1995-06-07 | 1998-02-17 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias with no discrete target |
US5954665A (en) * | 1995-06-07 | 1999-09-21 | Biosense, Inc. | Cardiac ablation catheter using correlation measure |
WO1997017893A1 (en) * | 1995-11-13 | 1997-05-22 | Heart Rhythm Technologies, Inc. | System and method for analyzing electrogram waveforms |
CA2242356C (en) | 1996-01-08 | 2005-08-23 | Biosense, Inc. | Methods and apparatus for myocardial revascularization |
DE69738813D1 (en) * | 1996-01-08 | 2008-08-14 | Biosense Webster Inc | mapping catheter |
EP0910300B1 (en) | 1996-02-15 | 2003-12-03 | Biosense, Inc. | Site marking probe |
JP3930052B2 (en) | 1996-02-15 | 2007-06-13 | バイオセンス・インコーポレイテッド | Catheter-based surgery |
IL125761A (en) | 1996-02-15 | 2005-05-17 | Biosense Inc | Independently positionable transducers for location system |
CA2246340C (en) | 1996-02-15 | 2005-08-16 | Biosense, Inc. | Catheter calibration and usage monitoring system |
DE69738274T2 (en) | 1996-02-15 | 2008-08-28 | Biosense Webster, Inc., Diamond Bar | Mobile receiving and transmitting coils for a location system |
EP0883375B1 (en) | 1996-02-15 | 2005-05-11 | Biosense Webster, Inc. | Precise position determination of endoscopes |
ES2251018T3 (en) | 1996-02-15 | 2006-04-16 | Biosense Webster, Inc. | CATHETER WITH LUMEN. |
CA2246288C (en) | 1996-02-15 | 2005-09-20 | Biosense, Inc. | Medical probes with field transducers |
JP4141500B2 (en) | 1996-02-27 | 2008-08-27 | バイオセンス・ウェブスター・インコーポレイテッド | Positioning device and operation method thereof |
US6443974B1 (en) | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
JP4236014B2 (en) | 1997-01-08 | 2009-03-11 | バイオセンス・ウェブスター・インコーポレイテッド | Monitoring myocardial vascular regeneration |
US6314310B1 (en) | 1997-02-14 | 2001-11-06 | Biosense, Inc. | X-ray guided surgical location system with extended mapping volume |
EP0893093A1 (en) * | 1997-07-25 | 1999-01-27 | Sulzer Osypka GmbH | Catheter for the endocardial detection of heart potentials |
US6490474B1 (en) | 1997-08-01 | 2002-12-03 | Cardiac Pathways Corporation | System and method for electrode localization using ultrasound |
US7806829B2 (en) | 1998-06-30 | 2010-10-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for navigating an ultrasound catheter to image a beating heart |
US6447504B1 (en) | 1998-07-02 | 2002-09-10 | Biosense, Inc. | System for treatment of heart tissue using viability map |
US6301496B1 (en) | 1998-07-24 | 2001-10-09 | Biosense, Inc. | Vector mapping of three-dimensionally reconstructed intrabody organs and method of display |
US6226542B1 (en) | 1998-07-24 | 2001-05-01 | Biosense, Inc. | Three-dimensional reconstruction of intrabody organs |
EP1023870B1 (en) | 1999-01-28 | 2004-09-22 | Ministero Dell' Universita' E Della Ricerca Scientifica E Tecnologica | Device for localization of endocardial electrodes |
US6385476B1 (en) | 1999-09-21 | 2002-05-07 | Biosense, Inc. | Method and apparatus for intracardially surveying a condition of a chamber of a heart |
US6892091B1 (en) * | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
JP4926359B2 (en) | 2000-05-03 | 2012-05-09 | シー・アール・バード・インコーポレーテッド | Apparatus and method for mapping and cauterization in electrophysiological procedures |
DE10027782A1 (en) * | 2000-06-07 | 2001-12-13 | Biotronik Mess & Therapieg | System for determining the intracorporeal position of a working catheter |
US6400981B1 (en) * | 2000-06-21 | 2002-06-04 | Biosense, Inc. | Rapid mapping of electrical activity in the heart |
US6650927B1 (en) | 2000-08-18 | 2003-11-18 | Biosense, Inc. | Rendering of diagnostic imaging data on a three-dimensional map |
US6633773B1 (en) | 2000-09-29 | 2003-10-14 | Biosene, Inc. | Area of interest reconstruction for surface of an organ using location data |
EP1383426B1 (en) | 2001-04-27 | 2008-12-24 | C.R. Bard, Inc. | Catheter for three dimensional mapping of electrical activity in blood vessels |
US7727229B2 (en) | 2001-05-01 | 2010-06-01 | C.R. Bard, Inc. | Method and apparatus for altering conduction properties in the heart and in adjacent vessels |
EP1418972A1 (en) * | 2001-05-01 | 2004-05-19 | C.R. Bard, Inc. | Method and apparatus for altering conduction properties along pathways in the heart and in vessels in conductive communication with the heart |
US6961602B2 (en) | 2001-12-31 | 2005-11-01 | Biosense Webster, Inc. | Catheter having multiple spines each having electrical mapping and location sensing capabilities |
EP1487366B1 (en) * | 2002-03-15 | 2007-08-08 | C.R. Bard, Inc. | Apparatus for control of ablation energy and electrogram acquisition through multiple common electrodes in an electrophysiology catheter |
US6957101B2 (en) | 2002-08-21 | 2005-10-18 | Joshua Porath | Transient event mapping in the heart |
US7001383B2 (en) | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
EP2213257B1 (en) | 2003-03-28 | 2013-04-24 | C. R. Bard, Inc. | Braided Mesh Catheter |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US8046049B2 (en) | 2004-02-23 | 2011-10-25 | Biosense Webster, Inc. | Robotically guided catheter |
US8007495B2 (en) * | 2004-03-31 | 2011-08-30 | Biosense Webster, Inc. | Catheter for circumferential ablation at or near a pulmonary vein |
JP2005323702A (en) * | 2004-05-13 | 2005-11-24 | Asahi Intecc Co Ltd | Medical treatment instrument |
US8249685B2 (en) | 2004-05-17 | 2012-08-21 | C.R. Bard, Inc. | Method and apparatus for mapping and/or ablation of cardiac tissue |
US7974674B2 (en) * | 2004-05-28 | 2011-07-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for surface modeling |
US8528565B2 (en) | 2004-05-28 | 2013-09-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated therapy delivery |
US8755864B2 (en) | 2004-05-28 | 2014-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for diagnostic data mapping |
US10863945B2 (en) | 2004-05-28 | 2020-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system with contact sensing feature |
US10258285B2 (en) | 2004-05-28 | 2019-04-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated creation of ablation lesions |
US7632265B2 (en) * | 2004-05-28 | 2009-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Radio frequency ablation servo catheter and method |
US9782130B2 (en) | 2004-05-28 | 2017-10-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system |
US20060036163A1 (en) * | 2004-07-19 | 2006-02-16 | Viswanathan Raju R | Method of, and apparatus for, controlling medical navigation systems |
US8155910B2 (en) | 2005-05-27 | 2012-04-10 | St. Jude Medical, Atrial Fibrillation Divison, Inc. | Robotically controlled catheter and method of its calibration |
US7536218B2 (en) * | 2005-07-15 | 2009-05-19 | Biosense Webster, Inc. | Hybrid magnetic-based and impedance-based position sensing |
KR101222860B1 (en) * | 2005-09-01 | 2013-01-16 | 삼성전자주식회사 | Optical pickup device |
US8229545B2 (en) | 2005-09-15 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for mapping complex fractionated electrogram information |
US8038625B2 (en) * | 2005-09-15 | 2011-10-18 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for three-dimensional mapping of electrophysiology information |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
WO2007114305A1 (en) * | 2006-03-31 | 2007-10-11 | National University Corporation Kyoto Institute Of Technology | Image processing device, ultrasonic imaging device using the same, and image processing method |
US7766896B2 (en) * | 2006-04-25 | 2010-08-03 | Boston Scientific Scimed, Inc. | Variable stiffness catheter assembly |
US7774051B2 (en) | 2006-05-17 | 2010-08-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for mapping electrophysiology information onto complex geometry |
US7988639B2 (en) * | 2006-05-17 | 2011-08-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for complex geometry modeling of anatomy using multiple surface models |
US7515954B2 (en) * | 2006-06-13 | 2009-04-07 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
EP2745773A3 (en) * | 2006-06-13 | 2014-07-02 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
US7729752B2 (en) | 2006-06-13 | 2010-06-01 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including resolution map |
US7505810B2 (en) * | 2006-06-13 | 2009-03-17 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including preprocessing |
EP2038002A4 (en) * | 2006-06-28 | 2010-12-29 | Bard Inc C R | Methods and apparatus for assessing and improving electrode contact with cardiac tissue |
CA2659898C (en) * | 2006-08-03 | 2017-08-29 | Christoph Scharf | Method and device for determining and presenting surface charge and dipole densities on cardiac walls |
US9370312B2 (en) | 2006-09-06 | 2016-06-21 | Biosense Webster, Inc. | Correlation of cardiac electrical maps with body surface measurements |
US8068920B2 (en) * | 2006-10-03 | 2011-11-29 | Vincent A Gaudiani | Transcoronary sinus pacing system, LV summit pacing, early mitral closure pacing, and methods therefor |
US20080119697A1 (en) * | 2006-11-20 | 2008-05-22 | General Electric Company | Bidirectional communication interface |
US7996055B2 (en) | 2006-12-29 | 2011-08-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Cardiac navigation system including electrode array for use therewith |
US9220439B2 (en) | 2006-12-29 | 2015-12-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Navigational reference dislodgement detection method and system |
US7957784B2 (en) * | 2006-12-29 | 2011-06-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Body surface mapping system |
US9585586B2 (en) | 2006-12-29 | 2017-03-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Navigational reference dislodgement detection method and system |
US8265745B2 (en) | 2006-12-29 | 2012-09-11 | St. Jude Medical, Atrial Fibillation Division, Inc. | Contact sensor and sheath exit sensor |
US20080190438A1 (en) * | 2007-02-08 | 2008-08-14 | Doron Harlev | Impedance registration and catheter tracking |
US8155756B2 (en) * | 2007-02-16 | 2012-04-10 | Pacesetter, Inc. | Motion-based optimization for placement of cardiac stimulation electrodes |
US8195292B2 (en) * | 2007-02-16 | 2012-06-05 | Pacestter, Inc. | Cardiac resynchronization therapy optimization using parameter estimation from realtime electrode motion tracking |
US9549689B2 (en) | 2007-03-09 | 2017-01-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for correction of inhomogeneous fields |
US10433929B2 (en) * | 2007-03-09 | 2019-10-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for local deformable registration of a catheter navigation system to image data or a model |
US7825925B2 (en) * | 2007-03-09 | 2010-11-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and system for repairing triangulated surface meshes |
US9757036B2 (en) * | 2007-05-08 | 2017-09-12 | Mediguide Ltd. | Method for producing an electrophysiological map of the heart |
WO2008136008A2 (en) * | 2007-05-08 | 2008-11-13 | Mediguide Ltd. | Method for producing an electrophysiological map of the heart |
JP5337367B2 (en) * | 2007-10-31 | 2013-11-06 | 株式会社東芝 | Medical image display device |
EP2197377B1 (en) | 2007-11-16 | 2017-11-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Device for real-time lesion estimation during ablation |
US9717501B2 (en) | 2007-11-21 | 2017-08-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for occluding vessels during cardiac ablation including optional electroanatomical guidance |
US8359092B2 (en) * | 2007-11-29 | 2013-01-22 | Biosense Webster, Inc. | Determining locations of ganglia and plexi in the heart using complex fractionated atrial electrogram |
US9622673B2 (en) * | 2007-12-14 | 2017-04-18 | Siemens Healthcare Gmbh | System for determining electrical status of patient attached leads |
US20090163801A1 (en) * | 2007-12-19 | 2009-06-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for displaying data relating to energy emitting treatment devices together with electrophysiological mapping data |
US8103327B2 (en) | 2007-12-28 | 2012-01-24 | Rhythmia Medical, Inc. | Cardiac mapping catheter |
CN101960489A (en) | 2007-12-31 | 2011-01-26 | 真实成像有限公司 | Method, apparatus and system for analyzing thermal images |
US8082035B2 (en) * | 2008-01-10 | 2011-12-20 | Bioness Inc. | Methods and apparatus for implanting electronic implants within the body |
EP2252203A2 (en) | 2008-01-17 | 2010-11-24 | Christoph Scharf | A device and method for the geometric determination of electrical dipole densities on the cardiac wall |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
WO2009118721A1 (en) * | 2008-03-28 | 2009-10-01 | Real Imaging Ltd. | Method apparatus and system for analyzing thermal images |
US8538509B2 (en) | 2008-04-02 | 2013-09-17 | Rhythmia Medical, Inc. | Intracardiac tracking system |
US20090276020A1 (en) * | 2008-05-02 | 2009-11-05 | Pacesetter, Inc. | Tools for delivering implantable medical leads and methods of using and manufacturing such tools |
ES2398052T5 (en) | 2008-05-09 | 2021-10-25 | Nuvaira Inc | Systems for treating a bronchial tree |
US8676303B2 (en) * | 2008-05-13 | 2014-03-18 | The Regents Of The University Of California | Methods and systems for treating heart instability |
US8467863B2 (en) * | 2008-08-22 | 2013-06-18 | Koninklijke Philips N.V. | Sensing apparatus for sensing an object |
WO2010042826A1 (en) | 2008-10-09 | 2010-04-15 | Sanjiv Narayan | Machine and process for the automatic localization of sources of biological rhythm disorders |
US8386010B2 (en) * | 2008-10-23 | 2013-02-26 | Covidien Lp | Surgical tissue monitoring system |
US8137343B2 (en) | 2008-10-27 | 2012-03-20 | Rhythmia Medical, Inc. | Tracking system using field mapping |
US9339331B2 (en) * | 2008-12-29 | 2016-05-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Non-contact electrode basket catheters with irrigation |
US8700129B2 (en) | 2008-12-31 | 2014-04-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for catheter localization |
US8900150B2 (en) | 2008-12-30 | 2014-12-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Intracardiac imaging system utilizing a multipurpose catheter |
US9307931B2 (en) * | 2008-12-31 | 2016-04-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multiple shell construction to emulate chamber contraction with a mapping system |
US9398862B2 (en) | 2009-04-23 | 2016-07-26 | Rhythmia Medical, Inc. | Multi-electrode mapping system |
US8571647B2 (en) | 2009-05-08 | 2013-10-29 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
US8103338B2 (en) * | 2009-05-08 | 2012-01-24 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
US9439735B2 (en) | 2009-06-08 | 2016-09-13 | MRI Interventions, Inc. | MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time |
US9211074B2 (en) * | 2009-06-09 | 2015-12-15 | Safeop Surgical, Inc. | System, method, apparatus, device and computer program product for automatically detecting positioning effect |
US8396532B2 (en) | 2009-06-16 | 2013-03-12 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8406848B2 (en) * | 2009-10-06 | 2013-03-26 | Seiko Epson Corporation | Reconstructing three-dimensional current sources from magnetic sensor data |
US10434319B2 (en) | 2009-10-09 | 2019-10-08 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US9332915B2 (en) | 2013-03-15 | 2016-05-10 | The Regents Of The University Of California | System and method to identify sources associated with biological rhythm disorders |
US10398326B2 (en) | 2013-03-15 | 2019-09-03 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US9392948B2 (en) | 2011-12-09 | 2016-07-19 | The Regents Of The University Of California | System and method of identifying sources for biological rhythms |
EP2493408B1 (en) | 2009-10-27 | 2015-06-24 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
KR101820542B1 (en) | 2009-11-11 | 2018-01-19 | 호라이라 인코포레이티드 | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US20110199286A1 (en) * | 2010-02-13 | 2011-08-18 | Robin Dziama | Spherical Electronic LCD Display |
US20110213260A1 (en) * | 2010-02-26 | 2011-09-01 | Pacesetter, Inc. | Crt lead placement based on optimal branch selection and optimal site selection |
KR20130057998A (en) | 2010-04-08 | 2013-06-03 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders |
US8694074B2 (en) | 2010-05-11 | 2014-04-08 | Rhythmia Medical, Inc. | Electrode displacement determination |
US8603004B2 (en) | 2010-07-13 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for filtering respiration noise from localization data |
US9539046B2 (en) | 2010-08-03 | 2017-01-10 | Medtronic Cryocath Lp | Cryogenic medical mapping and treatment device |
US9655666B2 (en) * | 2010-10-29 | 2017-05-23 | Medtronic Ablatio Frontiers LLC | Catheter with coronary sinus ostium anchor |
US8560086B2 (en) | 2010-12-02 | 2013-10-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter electrode assemblies and methods of construction therefor |
CN103220970B (en) | 2010-12-17 | 2016-03-09 | 圣犹达医疗用品电生理部门有限公司 | Navigational reference point bias detecting method and system |
US9095715B2 (en) | 2010-12-23 | 2015-08-04 | Medtronic, Inc. | Implanted device data to guide ablation therapy |
US9061155B2 (en) | 2010-12-23 | 2015-06-23 | Medtronic, Inc. | Implanted device data to guide ablation therapy |
US9002442B2 (en) | 2011-01-13 | 2015-04-07 | Rhythmia Medical, Inc. | Beat alignment and selection for cardiac mapping |
US8948837B2 (en) | 2011-01-13 | 2015-02-03 | Rhythmia Medical, Inc. | Electroanatomical mapping |
WO2012122517A2 (en) | 2011-03-10 | 2012-09-13 | Acutus Medical, Inc. | Device and method for the geometric determination of electrical dipole densities on the cardiac wall |
US9901303B2 (en) | 2011-04-14 | 2018-02-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for registration of multiple navigation systems to a common coordinate frame |
US10362963B2 (en) | 2011-04-14 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Correction of shift and drift in impedance-based medical device navigation using magnetic field information |
US10918307B2 (en) | 2011-09-13 | 2021-02-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter navigation using impedance and magnetic field measurements |
ITPD20110125A1 (en) * | 2011-04-15 | 2012-10-16 | Elvido Medical Technology Srl | CENTRAL VENOUS CATHETER |
WO2012145077A1 (en) | 2011-04-22 | 2012-10-26 | Topera, Inc. | Method for detection of cardiac rhythm disorders using basket style cardiac mapping catheter |
US9050006B2 (en) | 2011-05-02 | 2015-06-09 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
US8165666B1 (en) | 2011-05-02 | 2012-04-24 | Topera, Inc. | System and method for reconstructing cardiac activation information |
US9107600B2 (en) | 2011-05-02 | 2015-08-18 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
EP2705464B1 (en) | 2011-05-02 | 2018-04-18 | Topera, Inc. | System and method for targeting heart rhythm disorders using shaped ablation |
US10506948B2 (en) | 2011-07-05 | 2019-12-17 | Cardioinsight Technologies, Inc. | Localization for electrocardiographic mapping |
US9186515B2 (en) * | 2011-07-05 | 2015-11-17 | Cardioinsight Technologies, Inc. | System and methods to facilitate providing therapy to a patient |
US9387031B2 (en) | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US8620417B2 (en) | 2011-09-22 | 2013-12-31 | Biosense Webster (Israel), Ltd. | Graphic user interface for physical parameter mapping |
CN104023663B (en) | 2011-12-29 | 2018-12-21 | 圣犹达医疗用品电生理部门有限公司 | System for optimizing the damage that coupling ablation catheter to bodily tissue and assessment is formed by conduit |
CA3122358C (en) | 2012-05-02 | 2023-10-03 | Safeop Surgical Inc. | System, method, and computer algorithm for characterization and classification of electrophysiological evoked potentials |
US10588543B2 (en) | 2012-05-23 | 2020-03-17 | Biosense Webster (Israel), Ltd. | Position sensing using electric dipole fields |
CA2878588A1 (en) | 2012-07-30 | 2014-02-06 | Northwestern University | Radiofrequency probe for circumferential ablation of a hollow cavity |
JP6316821B2 (en) | 2012-08-31 | 2018-04-25 | アクタス メディカル インクAcutus Medical,Inc. | Ablation system |
US9113911B2 (en) | 2012-09-06 | 2015-08-25 | Medtronic Ablation Frontiers Llc | Ablation device and method for electroporating tissue cells |
US9895079B2 (en) * | 2012-09-26 | 2018-02-20 | Biosense Webster (Israel) Ltd. | Electropotential mapping |
WO2014100464A1 (en) | 2012-12-20 | 2014-06-26 | Boston Scientific Scimed, Inc. | Rotor identification using sequential pattern matching |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9693699B2 (en) | 2013-01-16 | 2017-07-04 | University Of Vermont | Methods and systems for mapping cardiac fibrillation |
US10912476B2 (en) | 2013-01-16 | 2021-02-09 | University Of Vermont | Catheters, systems, and related methods for mapping, minimizing, and treating cardiac fibrillation |
CN105358070B (en) | 2013-02-08 | 2018-03-23 | 阿库图森医疗有限公司 | Expandable catheter component with flexible printed circuit board |
US9026196B2 (en) | 2013-03-05 | 2015-05-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for detecting sheathing and unsheathing of localization elements |
US10188314B2 (en) | 2013-03-05 | 2019-01-29 | St. Jude Medical, Cardiology Division, Inc. | System and method for detecting sheathing and unsheathing of localization elements |
US9474486B2 (en) | 2013-03-08 | 2016-10-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket for a multi-electrode array catheter |
WO2014150509A1 (en) * | 2013-03-15 | 2014-09-25 | Intuitive Surgical Operations, Inc. | Shape sensor systems for tracking interventional instruments and methods of use |
US8715199B1 (en) | 2013-03-15 | 2014-05-06 | Topera, Inc. | System and method to define a rotational source associated with a biological rhythm disorder |
US9345540B2 (en) | 2013-03-15 | 2016-05-24 | Medtronic Ablation Frontiers Llc | Contact specific RF therapy balloon |
US20140330270A1 (en) * | 2013-05-03 | 2014-11-06 | William J. Anderson | Method of ablating scar tissue to orient electrical current flow |
US9636032B2 (en) | 2013-05-06 | 2017-05-02 | Boston Scientific Scimed Inc. | Persistent display of nearest beat characteristics during real-time or play-back electrophysiology data visualization |
EP2956055B1 (en) * | 2013-05-07 | 2020-07-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Utilization of electrode spatial arrangements for characterizing cardiac conduction conditions |
JP6182665B2 (en) | 2013-05-14 | 2017-08-16 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Catheter system for the display and identification of activity patterns during electrophysiological mapping using vector fields |
CN105307558B (en) | 2013-05-16 | 2017-11-28 | 波士顿科学医学有限公司 | Optimized by the exciting time started of the enhancing based on homophylic pattern match |
US9576107B2 (en) * | 2013-07-09 | 2017-02-21 | Biosense Webster (Israel) Ltd. | Model based reconstruction of the heart from sparse samples |
US9775578B2 (en) | 2013-08-12 | 2017-10-03 | Biosense Webster (Israel) Ltd. | Unmapped region visualization |
CN105473066A (en) | 2013-08-20 | 2016-04-06 | 圣犹达医疗用品电生理部门有限公司 | System and method for generating electrophysiology maps |
JP2016530008A (en) | 2013-08-28 | 2016-09-29 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Predicting the prevalence of activation patterns in data segments during electrophysiological mapping |
AU2014318872B2 (en) | 2013-09-13 | 2018-09-13 | Acutus Medical, Inc. | Devices and methods for determination of electrical dipole densities on a cardiac surface |
US9220435B2 (en) | 2013-10-09 | 2015-12-29 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating electrophysiology maps |
CN105592778B (en) | 2013-10-14 | 2019-07-23 | 波士顿科学医学有限公司 | High-resolution cardiac mapping electrod-array conduit |
US9730600B2 (en) * | 2013-10-31 | 2017-08-15 | Boston Scientific Scimed, Inc. | Medical device for high resolution mapping using localized matching |
US9717429B2 (en) | 2013-10-31 | 2017-08-01 | St. Jude Medical, Cardiology Division, Inc. | System and method for analyzing biological signals and generating electrophyisology maps |
US9814406B2 (en) | 2013-11-19 | 2017-11-14 | Pacesetter, Inc. | Method and system to identify motion data associated with consistent electrical and mechanical behavior for a region of interest |
US9301713B2 (en) | 2013-11-19 | 2016-04-05 | Pacesetter, Inc. | Method and system to assess mechanical dyssynchrony based on motion data collected by a navigation system |
US9314191B2 (en) | 2013-11-19 | 2016-04-19 | Pacesetter, Inc. | Method and system to measure cardiac motion using a cardiovascular navigation system |
US10568686B2 (en) * | 2013-11-21 | 2020-02-25 | Biosense Webster (Israel) Ltd. | Multi-electrode balloon catheter with circumferential and point electrodes |
WO2015095577A1 (en) | 2013-12-20 | 2015-06-25 | St. Jude Medical, Cardiology Division, Inc. | Coaxial electrode catheters for extracting electrophysiologic parameters |
WO2015148470A1 (en) | 2014-03-25 | 2015-10-01 | Acutus Medical, Inc. | Cardiac analysis user interface system and method |
US9380940B2 (en) | 2014-05-05 | 2016-07-05 | Pacesetter, Inc. | Method and system for displaying a three dimensional visualization of cardiac motion |
US9895076B2 (en) | 2014-05-05 | 2018-02-20 | Pacesetter, Inc. | Method and system to determine cardiac cycle length in connection with cardiac mapping |
US9700233B2 (en) | 2014-05-05 | 2017-07-11 | Pacesetter, Inc. | Method and system to equalizing cardiac cycle length between map points |
US9364170B2 (en) | 2014-05-05 | 2016-06-14 | Pacesetter, Inc. | Method and system to characterize motion data based on neighboring map points |
US9861823B2 (en) | 2014-05-05 | 2018-01-09 | Pacesetter, Inc. | Cardiac resynchronization system and method |
US9763591B2 (en) | 2014-05-05 | 2017-09-19 | Pacesetter, Inc. | Method and system to subdivide a mapping area for mechanical activation analysis |
US9302099B2 (en) | 2014-05-05 | 2016-04-05 | Pacesetter, Inc. | System and method for evaluating lead stability of an implantable medical device |
US10105077B2 (en) | 2014-05-05 | 2018-10-23 | Pacesetter, Inc. | Method and system for calculating strain from characterization data of a cardiac chamber |
US10285647B2 (en) | 2014-05-05 | 2019-05-14 | Pacesetter Inc. | Method and system to automatically assign map points to anatomical segments and determine mechanical activation time |
US9585588B2 (en) | 2014-06-03 | 2017-03-07 | Boston Scientific Scimed, Inc. | Electrode assembly having an atraumatic distal tip |
JP2017516588A (en) | 2014-06-04 | 2017-06-22 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Electrode assembly |
EP3157419A1 (en) | 2014-06-20 | 2017-04-26 | Boston Scientific Scimed Inc. | Medical devices for mapping cardiac tissue |
CN107148552B (en) | 2014-09-26 | 2020-09-18 | 科迪影技术股份有限公司 | Positioning of objects within a conductive volume |
WO2016061387A1 (en) | 2014-10-15 | 2016-04-21 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for generating integrated substrate maps for cardiac arrhythmias |
WO2016061384A1 (en) | 2014-10-15 | 2016-04-21 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for mapping local conduction velocity |
CN112604152A (en) * | 2014-11-09 | 2021-04-06 | 森索医疗实验有限公司 | Electrode lead |
US20170354395A1 (en) | 2015-01-07 | 2017-12-14 | St. Jude Medical, Cardiology Division, Inc. | Imaging Device |
EP3206575A1 (en) | 2015-01-07 | 2017-08-23 | St. Jude Medical, Cardiology Division, Inc. | System, method, and apparatus for visualizing cardiac timing information using animations |
US9833161B2 (en) * | 2015-02-09 | 2017-12-05 | Biosense Webster (Israel) Ltd. | Basket catheter with far-field electrode |
EP3288478B1 (en) | 2015-04-29 | 2019-12-25 | Innoblative Designs, Inc. | Cavitary tissue ablation |
WO2016176009A1 (en) | 2015-04-30 | 2016-11-03 | The Regents Of The University Of Michigan | Method and system for mapping and analyzing cardiac electrical activity |
CN107530014B (en) | 2015-05-04 | 2021-12-10 | 赛佛欧普手术有限公司 | System, method and computer algorithm for measuring, displaying and accurately detecting changes in electrophysiological evoked potentials |
WO2016179454A1 (en) | 2015-05-07 | 2016-11-10 | St. Jude Medical, Cardiology Division, Inc. | System and method for detecting sheathing and unsheathing of localization elements |
EP3261531B1 (en) | 2015-05-08 | 2020-08-26 | St. Jude Medical, Cardiology Division, Inc. | System and method for real-time electrophysiological mapping |
CN107635503B (en) | 2015-05-12 | 2021-09-07 | 纳维斯国际有限公司 | Damage estimation by dielectric property analysis |
EP3294127A1 (en) | 2015-05-12 | 2018-03-21 | Navix International Limited | Systems and methods for tracking an intrabody catheter |
WO2016181320A1 (en) | 2015-05-12 | 2016-11-17 | Navix International Limited | Fiducial marking for image-electromagnetic field registration |
CN107847173B (en) | 2015-05-12 | 2022-08-30 | 阿库图森医疗有限公司 | Ultrasonic sequencing system and method |
WO2016183179A1 (en) | 2015-05-12 | 2016-11-17 | Acutus Medical, Inc. | Cardiac virtualization test tank and testing system and method |
EP3294174B1 (en) | 2015-05-12 | 2022-12-14 | Navix International Limited | Contact quality assessment by dielectric property analysis |
WO2016183468A1 (en) * | 2015-05-13 | 2016-11-17 | Acutus Medical, Inc. | Localization system and method useful in the acquisition and analysis of cardiac information |
WO2017031197A1 (en) | 2015-08-20 | 2017-02-23 | Boston Scientific Scimed Inc. | Flexible electrode for cardiac sensing and method for making |
WO2017040581A1 (en) | 2015-09-02 | 2017-03-09 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for identifying and mapping cardiac activation wavefronts |
EP3346915A4 (en) | 2015-09-07 | 2018-10-10 | Ablacon Inc. | Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart |
US10405766B2 (en) | 2015-09-26 | 2019-09-10 | Boston Scientific Scimed, Inc. | Method of exploring or mapping internal cardiac structures |
EP3353753A1 (en) | 2015-09-26 | 2018-08-01 | Boston Scientific Scimed Inc. | Systems and methods for anatomical shell editing |
EP3352648B1 (en) | 2015-09-26 | 2022-10-26 | Boston Scientific Scimed Inc. | Multiple rhythm template monitoring |
EP3352662B1 (en) | 2015-09-26 | 2019-08-14 | Boston Scientific Scimed Inc. | Intracardiac egm signals for beat matching and acceptance |
WO2017062247A1 (en) | 2015-10-07 | 2017-04-13 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for mapping cardiac repolarization |
CN108348186B (en) | 2015-10-07 | 2021-06-18 | 圣犹达医疗用品心脏病学部门有限公司 | Method and system for mapping cardiac restitution |
US9848936B2 (en) | 2015-10-29 | 2017-12-26 | Innoblative Designs, Inc. | Screen sphere tissue ablation devices and methods |
CN108471975B (en) | 2015-12-04 | 2020-11-17 | 圣犹达医疗用品心脏病学部门有限公司 | Method and system for statistically analyzing electrograms of and mapping locally abnormal ventricular activity |
US10362953B2 (en) * | 2015-12-11 | 2019-07-30 | Biosense Webster (Israel) Ltd. | Electrode array catheter with interconnected framework |
WO2017136261A1 (en) | 2016-02-02 | 2017-08-10 | Innoblative Designs, Inc. | Cavitary tissue ablation system |
WO2017142850A1 (en) | 2016-02-16 | 2017-08-24 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for electrophysiology mapping using medical images |
US10869714B2 (en) | 2016-03-01 | 2020-12-22 | Innoblative Designs, Inc. | Resecting and coagulating tissue |
WO2017151347A1 (en) | 2016-03-01 | 2017-09-08 | St. Jude Medical, Cardiology Division, Inc. | Methods and systems for mapping cardiac activity |
US11399759B2 (en) | 2016-05-03 | 2022-08-02 | Acutus Medical, Inc. | Cardiac mapping system with efficiency algorithm |
US10987091B2 (en) | 2016-05-17 | 2021-04-27 | Biosense Webster (Israel) Ltd. | System and method for catheter connections |
WO2018011757A1 (en) | 2016-07-14 | 2018-01-18 | Navix International Limited | Characteristic track catheter navigation |
JP2019536509A (en) | 2016-10-17 | 2019-12-19 | イノブレイティブ デザインズ, インコーポレイテッド | Treatment device and method |
US11266467B2 (en) | 2016-10-25 | 2022-03-08 | Navix International Limited | Systems and methods for registration of intra-body electrical readings with a pre-acquired three dimensional image |
WO2018144090A2 (en) | 2016-11-08 | 2018-08-09 | Innoblative Designs, Inc. | Electrosurgical tissue and vessel sealing device |
US10561325B2 (en) | 2016-11-11 | 2020-02-18 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating electrophysiology maps |
WO2018092071A1 (en) | 2016-11-16 | 2018-05-24 | Navix International Limited | Estimators for ablation effectiveness |
CN110072449B (en) | 2016-11-16 | 2023-02-24 | 纳维斯国际有限公司 | Esophageal position detection by electrical mapping |
US11284813B2 (en) | 2016-11-16 | 2022-03-29 | Navix International Limited | Real-time display of tissue deformation by interactions with an intra-body probe |
WO2018092063A1 (en) | 2016-11-16 | 2018-05-24 | Navix International Limited | Real-time display of treatment-related tissue changes using virtual material |
CN110177500B (en) | 2016-11-16 | 2022-03-04 | 纳维斯国际有限公司 | Dynamic visual rendering of tissue models |
US11344236B2 (en) | 2016-11-21 | 2022-05-31 | St Jude Medical Cardiology Division, Inc. | System and method for generating electrophysiology maps |
CN106691438B (en) * | 2016-12-07 | 2022-05-31 | 首都医科大学附属北京安贞医院 | Whole heart three-dimensional mapping system for complex arrhythmia |
US11471067B2 (en) | 2017-01-12 | 2022-10-18 | Navix International Limited | Intrabody probe navigation by electrical self-sensing |
WO2018130974A1 (en) | 2017-01-12 | 2018-07-19 | Navix International Limited | Systems and methods for reconstruction of intra-body electrical readings to anatomical structure |
US11730395B2 (en) | 2017-01-12 | 2023-08-22 | Navix International Limited | Reconstruction of an anatomical structure from intrabody measurements |
WO2018132543A1 (en) | 2017-01-13 | 2018-07-19 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating premature ventricular contraction electrophysiology maps |
US10893819B2 (en) | 2017-01-25 | 2021-01-19 | Biosense Webster (Israel) Ltd. | Analyzing and mapping ECG signals and determining ablation points to eliminate Brugada syndrome |
US10952793B2 (en) | 2017-01-25 | 2021-03-23 | Biosense Webster (Israel) Ltd. | Method and system for eliminating a broad range of cardiac conditions by analyzing intracardiac signals providing a detailed map and determining potential ablation points |
US10888379B2 (en) | 2017-01-25 | 2021-01-12 | Biosense Webster (Israel) Ltd. | Analyzing and mapping ECG signals and determining ablation points to eliminate brugada syndrome |
WO2018160631A1 (en) | 2017-03-02 | 2018-09-07 | St. Jude Medical, Cardiology Division, Inc. | System and method for differentiation of adipose tissue from scar tissue during electrophysiological mapping |
WO2018204375A1 (en) | 2017-05-04 | 2018-11-08 | St. Jude Medical, Cardiology Division, Inc. | System and method for determining ablation parameters |
CN110622254B (en) | 2017-05-17 | 2024-04-05 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for mapping local activation times |
US20180344202A1 (en) * | 2017-05-30 | 2018-12-06 | Biosense Webster (Israel) Ltd. | Catheter Splines as Location Sensors |
EP3609388A1 (en) | 2017-07-07 | 2020-02-19 | St. Jude Medical, Cardiology Division, Inc. | System and method for electrophysiological mapping |
US11564606B2 (en) | 2017-07-19 | 2023-01-31 | St. Jude Medical, Cardiology Division, Inc. | System and method for electrophysiological mapping |
US11786297B2 (en) | 2017-07-26 | 2023-10-17 | Innoblative Designs, Inc. | Minimally invasive articulating assembly having ablation capabilities |
CN111050641B (en) | 2017-08-17 | 2023-06-09 | 纳维斯国际有限公司 | Remote imaging based on field gradients |
WO2019046250A1 (en) | 2017-09-01 | 2019-03-07 | St. Jude Medical, Cardiology Division, Inc. | System and method for visualizing a proximity of a catheter electrode to a 3d geometry of biological tissue |
WO2019055115A1 (en) | 2017-09-18 | 2019-03-21 | St. Jude Medical, Cardiology Division, Inc. | System and method for sorting electrophysiological signals from multi-dimensional catheters |
US10532187B2 (en) | 2017-10-17 | 2020-01-14 | Biosense Webster (Israel) Ltd. | Reusable catheter handle system |
US10575746B2 (en) | 2017-12-14 | 2020-03-03 | Biosense Webster (Israel) Ltd. | Epicardial mapping |
CN111557034B (en) | 2018-01-09 | 2023-12-29 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for classifying electrophysiological signals on a virtual catheter |
CN111655141B (en) | 2018-02-12 | 2024-03-19 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for mapping myocardial fiber orientation |
US11103177B2 (en) | 2018-04-18 | 2021-08-31 | St, Jude Medical, Cardiology Division, Inc. | System and method for mapping cardiac activity |
WO2019209626A1 (en) | 2018-04-26 | 2019-10-31 | St. Jude Medical, Cardiology Division, Inc. | System and method for mapping arrhythmic driver sites |
US11071486B2 (en) | 2018-06-01 | 2021-07-27 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating activation timing maps |
US20210118572A1 (en) | 2018-06-14 | 2021-04-22 | St. Jude Medical, Cardiology Division, Inc. | System and Method for Mapping Cardiac Activity |
CN112368747A (en) | 2018-09-10 | 2021-02-12 | 圣犹达医疗用品心脏病学部门有限公司 | System and method for displaying electrophysiological signals from a multi-dimensional catheter |
WO2020055506A1 (en) | 2018-09-12 | 2020-03-19 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating three dimensional geometric models of anatomical regions |
US11577075B1 (en) | 2018-10-12 | 2023-02-14 | Vincent A. Gaudiani | Transcoronary sinus pacing of his bundle |
US11648397B1 (en) | 2018-10-12 | 2023-05-16 | Vincent Gaudiani | Transcoronary sinus pacing of posteroseptal left ventricular base |
US11559362B2 (en) * | 2018-11-20 | 2023-01-24 | Boston Scientific Scimed, Inc. | Systems and methods for autonomous cardiac mapping |
EP3846684B1 (en) | 2019-01-03 | 2023-02-01 | St. Jude Medical, Cardiology Division, Inc. | System and method for mapping cardiac activation wavefronts |
WO2020185503A1 (en) | 2019-03-08 | 2020-09-17 | St Jude Medical, Cardiology Division, Inc. | High density electrode catheters |
US20220142553A1 (en) | 2019-03-12 | 2022-05-12 | St. Jude Medical, Cardiology Division, Inc. | System and method for cardiac mapping |
US20220167899A1 (en) | 2019-04-04 | 2022-06-02 | St. Jude Medical Cardiology Division, Inc. | System and method for cardiac mapping |
CN113710157A (en) | 2019-04-18 | 2021-11-26 | 圣犹达医疗用品心脏病学部门有限公司 | Systems and methods for cardiac mapping |
EP3948825A1 (en) | 2019-04-24 | 2022-02-09 | St. Jude Medical, Cardiology Division, Inc. | System, method, and apparatus for visualizing cardiac activation |
EP3923796B1 (en) | 2019-05-09 | 2022-12-07 | St. Jude Medical, Cardiology Division, Inc. | System and method for detection and mapping of near field conduction in scar tissue |
US11564610B2 (en) | 2019-05-23 | 2023-01-31 | Biosense Webster (Israel) Ltd. | Volumetric LAT map |
CN113795196A (en) | 2019-05-24 | 2021-12-14 | 圣犹达医疗用品心脏病学部门有限公司 | Systems and methods for cardiac mapping |
US10939863B2 (en) * | 2019-05-28 | 2021-03-09 | Biosense Webster (Israel) Ltd. | Determining occurrence of focal and/or rotor arrhythmogenic activity in cardiac tissue regions |
US11717139B2 (en) | 2019-06-19 | 2023-08-08 | Bolt Medical, Inc. | Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium |
WO2020256898A1 (en) | 2019-06-19 | 2020-12-24 | Boston Scientific Scimed, Inc. | Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions |
US11660427B2 (en) | 2019-06-24 | 2023-05-30 | Boston Scientific Scimed, Inc. | Superheating system for inertial impulse generation to disrupt vascular lesions |
US20200406010A1 (en) | 2019-06-26 | 2020-12-31 | Boston Scientific Scimed, Inc. | Side light direction plasma system to disrupt vascular lesions |
US11583339B2 (en) | 2019-10-31 | 2023-02-21 | Bolt Medical, Inc. | Asymmetrical balloon for intravascular lithotripsy device and method |
US11504023B2 (en) | 2019-12-16 | 2022-11-22 | Biosense Webster (Israel) Ltd. | Sparse calibration of magnetic field created by coils in metal-rich environment |
US20230039065A1 (en) | 2020-01-24 | 2023-02-09 | St. Jude Medical, Cardiology Division, Inc. | System and method for generating three dimensional geometric models of anatomical regions |
US11672599B2 (en) | 2020-03-09 | 2023-06-13 | Bolt Medical, Inc. | Acoustic performance monitoring system and method within intravascular lithotripsy device |
JP2023518239A (en) | 2020-03-16 | 2023-04-28 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Systems, methods, and apparatus for mapping local activation times |
US20210290286A1 (en) | 2020-03-18 | 2021-09-23 | Bolt Medical, Inc. | Optical analyzer assembly and method for intravascular lithotripsy device |
US11707323B2 (en) | 2020-04-03 | 2023-07-25 | Bolt Medical, Inc. | Electrical analyzer assembly for intravascular lithotripsy device |
JP7442677B2 (en) | 2020-04-21 | 2024-03-04 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | System and method for mapping cardiac activity |
JP7442685B2 (en) | 2020-05-19 | 2024-03-04 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Systems and methods for mapping electrophysiological excitation |
US11896317B2 (en) | 2020-08-04 | 2024-02-13 | Mazor Robotics Ltd. | Triangulation of item in patient body |
US11672585B2 (en) | 2021-01-12 | 2023-06-13 | Bolt Medical, Inc. | Balloon assembly for valvuloplasty catheter system |
JP2024509644A (en) * | 2021-04-07 | 2024-03-04 | ビーティーエル メディカル デベロップメント エー.エス. | Pulsed field ablation device and method |
US11648057B2 (en) | 2021-05-10 | 2023-05-16 | Bolt Medical, Inc. | Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device |
US11806075B2 (en) | 2021-06-07 | 2023-11-07 | Bolt Medical, Inc. | Active alignment system and method for laser optical coupling |
WO2023028133A1 (en) | 2021-08-26 | 2023-03-02 | St. Jude Medical, Cardiology Division, Inc. | Method and system for generating respiration signals for use in electrophysiology procedures |
US11839391B2 (en) | 2021-12-14 | 2023-12-12 | Bolt Medical, Inc. | Optical emitter housing assembly for intravascular lithotripsy device |
WO2023114588A1 (en) | 2021-12-17 | 2023-06-22 | St. Jude Medical, Cardiology Division, Inc. | Method and system for visualizing ablation procedure data |
JP2023122622A (en) | 2022-02-23 | 2023-09-04 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Method and system for tracking and visualizing medical devices |
Family Cites Families (127)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042486A (en) * | 1974-06-24 | 1977-08-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Process for the conversion of pitch into crystalloidal pitch |
US3954098A (en) * | 1975-01-31 | 1976-05-04 | Dick Donald E | Synchronized multiple image tomographic cardiography |
US4173228A (en) | 1977-05-16 | 1979-11-06 | Applied Medical Devices | Catheter locating device |
US4380237A (en) * | 1979-12-03 | 1983-04-19 | Massachusetts General Hospital | Apparatus for making cardiac output conductivity measurements |
US4304239A (en) * | 1980-03-07 | 1981-12-08 | The Kendall Company | Esophageal probe with balloon electrode |
US4431005A (en) | 1981-05-07 | 1984-02-14 | Mccormick Laboratories, Inc. | Method of and apparatus for determining very accurately the position of a device inside biological tissue |
US4750494A (en) * | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4444195A (en) * | 1981-11-02 | 1984-04-24 | Cordis Corporation | Cardiac lead having multiple ring electrodes |
US4572206A (en) * | 1982-04-21 | 1986-02-25 | Purdue Research Foundation | Method and apparatus for measuring cardiac output |
US4572486A (en) * | 1982-07-14 | 1986-02-25 | Metcast Associates, Inc. | Molten metal filtering vessel with internal filter |
US4559951A (en) * | 1982-11-29 | 1985-12-24 | Cardiac Pacemakers, Inc. | Catheter assembly |
US4478223A (en) * | 1982-12-06 | 1984-10-23 | Allor Douglas R | Three dimensional electrocardiograph |
US4613866A (en) | 1983-05-13 | 1986-09-23 | Mcdonnell Douglas Corporation | Three dimensional digitizer with electromagnetic coupling |
US4522212A (en) * | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
US4572186A (en) * | 1983-12-07 | 1986-02-25 | Cordis Corporation | Vessel dilation |
US4573473A (en) * | 1984-04-13 | 1986-03-04 | Cordis Corporation | Cardiac mapping probe |
US4697595A (en) | 1984-07-24 | 1987-10-06 | Telectronics N.V. | Ultrasonically marked cardiac catheters |
US4628937A (en) * | 1984-08-02 | 1986-12-16 | Cordis Corporation | Mapping electrode assembly |
CA1265586A (en) * | 1984-08-14 | 1990-02-06 | Consiglio Nazionale Delle Ricerche | Method and device for quick location of starting site of ventricular arrhythmias |
US4660571A (en) * | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4706670A (en) * | 1985-11-26 | 1987-11-17 | Meadox Surgimed A/S | Dilatation catheter |
US4674518A (en) * | 1985-09-06 | 1987-06-23 | Cardiac Pacemakers, Inc. | Method and apparatus for measuring ventricular volume |
US4699147A (en) * | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
DE3536658A1 (en) * | 1985-10-15 | 1987-04-16 | Kessler Manfred | METHOD FOR REPRESENTING ELECTROCARDIOGRAPHIC VALUES |
US4641649A (en) * | 1985-10-30 | 1987-02-10 | Rca Corporation | Method and apparatus for high frequency catheter ablation |
US4721115A (en) * | 1986-02-27 | 1988-01-26 | Cardiac Pacemakers, Inc. | Diagnostic catheter for monitoring cardiac output |
US4821731A (en) | 1986-04-25 | 1989-04-18 | Intra-Sonix, Inc. | Acoustic image system and method |
US4945305A (en) | 1986-10-09 | 1990-07-31 | Ascension Technology Corporation | Device for quantitatively measuring the relative position and orientation of two bodies in the presence of metals utilizing direct current magnetic fields |
US4940064A (en) * | 1986-11-14 | 1990-07-10 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
EP0312495A3 (en) * | 1987-10-16 | 1989-08-30 | Institut Straumann Ag | Electrical cable for carrying out at least one stimulation and/or measurement in a human or animal body |
US4922912A (en) * | 1987-10-21 | 1990-05-08 | Hideto Watanabe | MAP catheter |
FR2622098B1 (en) | 1987-10-27 | 1990-03-16 | Glace Christian | METHOD AND AZIMUTAL PROBE FOR LOCATING THE EMERGENCY POINT OF VENTRICULAR TACHYCARDIES |
US4777955A (en) * | 1987-11-02 | 1988-10-18 | Cordis Corporation | Left ventricle mapping probe |
GB2212267B (en) | 1987-11-11 | 1992-07-29 | Circulation Res Ltd | Methods and apparatus for the examination and treatment of internal organs |
JP2535988B2 (en) * | 1987-12-11 | 1996-09-18 | 株式会社ニコン | Three-dimensional multi-pattern photometer |
US4890623A (en) * | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
US5372138A (en) | 1988-03-21 | 1994-12-13 | Boston Scientific Corporation | Acousting imaging catheters and the like |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US4840182A (en) * | 1988-04-04 | 1989-06-20 | Rhode Island Hospital | Conductance catheter |
US4899750A (en) * | 1988-04-19 | 1990-02-13 | Siemens-Pacesetter, Inc. | Lead impedance scanning system for pacemakers |
JPH0748316B2 (en) * | 1988-05-30 | 1995-05-24 | 日本電気株式会社 | Dual port memory circuit |
CA1327838C (en) * | 1988-06-13 | 1994-03-15 | Fred Zacouto | Implantable device to prevent blood clotting disorders |
US4951682A (en) * | 1988-06-22 | 1990-08-28 | The Cleveland Clinic Foundation | Continuous cardiac output by impedance measurements in the heart |
US4898176A (en) * | 1988-06-22 | 1990-02-06 | The Cleveland Clinic Foundation | Continuous cardiac output by impedance measurements in the heart |
US5000190A (en) * | 1988-06-22 | 1991-03-19 | The Cleveland Clinic Foundation | Continuous cardiac output by impedance measurements in the heart |
US5054496A (en) | 1988-07-15 | 1991-10-08 | China-Japan Friendship Hospital | Method and apparatus for recording and analyzing body surface electrocardiographic peak maps |
US5025786A (en) * | 1988-07-21 | 1991-06-25 | Siegel Sharon B | Intracardiac catheter and method for detecting and diagnosing myocardial ischemia |
US4911174A (en) * | 1989-02-13 | 1990-03-27 | Cardiac Pacemakers, Inc. | Method for matching the sense length of an impedance measuring catheter to a ventricular chamber |
GB2233094B (en) * | 1989-05-26 | 1994-02-09 | Circulation Res Ltd | Methods and apparatus for the examination and treatment of internal organs |
US5029588A (en) * | 1989-06-15 | 1991-07-09 | Cardiovascular Imaging Systems, Inc. | Laser catheter with imaging capability |
US5056517A (en) | 1989-07-24 | 1991-10-15 | Consiglio Nazionale Delle Ricerche | Biomagnetically localizable multipurpose catheter and method for magnetocardiographic guided intracardiac mapping, biopsy and ablation of cardiac arrhythmias |
US5220924A (en) | 1989-09-28 | 1993-06-22 | Frazin Leon J | Doppler-guided retrograde catheterization using transducer equipped guide wire |
EP0419729A1 (en) | 1989-09-29 | 1991-04-03 | Siemens Aktiengesellschaft | Position finding of a catheter by means of non-ionising fields |
US5005587A (en) * | 1989-11-13 | 1991-04-09 | Pacing Systems, Inc. | Braid Electrode leads and catheters and methods for using the same |
JPH03224552A (en) * | 1990-01-31 | 1991-10-03 | Toshiba Corp | Ultrasonic diagnostic device |
US5253078A (en) * | 1990-03-14 | 1993-10-12 | C-Cube Microsystems, Inc. | System for compression and decompression of video data using discrete cosine transform and coding techniques |
US5360006A (en) * | 1990-06-12 | 1994-11-01 | University Of Florida Research Foundation, Inc. | Automated method for digital image quantitation |
US5273038A (en) * | 1990-07-09 | 1993-12-28 | Beavin William C | Computer simulation of live organ |
US5058583A (en) * | 1990-07-13 | 1991-10-22 | Geddes Leslie A | Multiple monopolar system and method of measuring stroke volume of the heart |
US5054492A (en) | 1990-12-17 | 1991-10-08 | Cardiovascular Imaging Systems, Inc. | Ultrasonic imaging catheter having rotational image correlation |
US5156151A (en) * | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
US5228442A (en) | 1991-02-15 | 1993-07-20 | Cardiac Pathways Corporation | Method for mapping, ablation, and stimulation using an endocardial catheter |
US5345936A (en) * | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5161536A (en) | 1991-03-22 | 1992-11-10 | Catheter Technology | Ultrasonic position indicating apparatus and methods |
US5433729A (en) | 1991-04-12 | 1995-07-18 | Incontrol, Inc. | Atrial defibrillator, lead systems, and method |
US5255678A (en) * | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5282471A (en) * | 1991-07-31 | 1994-02-01 | Kabushiki Kaisha Toshiba | Ultrasonic imaging system capable of displaying 3-dimensional angiogram in real time mode |
EP0531081A1 (en) | 1991-09-03 | 1993-03-10 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency fields |
US5211165A (en) | 1991-09-03 | 1993-05-18 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency field gradients |
US5713363A (en) | 1991-11-08 | 1998-02-03 | Mayo Foundation For Medical Education And Research | Ultrasound catheter and method for imaging and hemodynamic monitoring |
US5325860A (en) | 1991-11-08 | 1994-07-05 | Mayo Foundation For Medical Education And Research | Ultrasonic and interventional catheter and method |
US5222501A (en) | 1992-01-31 | 1993-06-29 | Duke University | Methods for the diagnosis and ablation treatment of ventricular tachycardia |
US5237996A (en) * | 1992-02-11 | 1993-08-24 | Waldman Lewis K | Endocardial electrical mapping catheter |
US5295484A (en) | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
US5255679A (en) | 1992-06-02 | 1993-10-26 | Cardiac Pathways Corporation | Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method |
US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
US5411025A (en) * | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
US5341807A (en) * | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US6603996B1 (en) * | 2000-06-07 | 2003-08-05 | Graydon Ernest Beatty | Software for mapping potential distribution of a heart chamber |
US5311866A (en) * | 1992-09-23 | 1994-05-17 | Endocardial Therapeutics, Inc. | Heart mapping catheter |
CA2678625A1 (en) | 1992-09-23 | 1994-03-31 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Endocardial mapping system |
US5553611A (en) * | 1994-01-06 | 1996-09-10 | Endocardial Solutions, Inc. | Endocardial measurement method |
US5297549A (en) * | 1992-09-23 | 1994-03-29 | Endocardial Therapeutics, Inc. | Endocardial mapping system |
US5662108A (en) * | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
US5622174A (en) * | 1992-10-02 | 1997-04-22 | Kabushiki Kaisha Toshiba | Ultrasonic diagnosis apparatus and image displaying system |
US5687737A (en) | 1992-10-09 | 1997-11-18 | Washington University | Computerized three-dimensional cardiac mapping with interactive visual displays |
US5385146A (en) | 1993-01-08 | 1995-01-31 | Goldreyer; Bruce N. | Orthogonal sensing for use in clinical electrophysiology |
US5433198A (en) | 1993-03-11 | 1995-07-18 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
US5601084A (en) * | 1993-06-23 | 1997-02-11 | University Of Washington | Determining cardiac wall thickness and motion by imaging and three-dimensional modeling |
WO1995001751A1 (en) | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5840031A (en) | 1993-07-01 | 1998-11-24 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials and ablating tissue |
US5551426A (en) * | 1993-07-14 | 1996-09-03 | Hummel; John D. | Intracardiac ablation and mapping catheter |
US5738096A (en) | 1993-07-20 | 1998-04-14 | Biosense, Inc. | Cardiac electromechanics |
US5391199A (en) | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
US5409000A (en) * | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5908446A (en) * | 1994-07-07 | 1999-06-01 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
US5558091A (en) | 1993-10-06 | 1996-09-24 | Biosense, Inc. | Magnetic determination of position and orientation |
US5458126A (en) * | 1994-02-24 | 1995-10-17 | General Electric Company | Cardiac functional analysis system employing gradient image segmentation |
US5661108A (en) * | 1994-06-01 | 1997-08-26 | Fmc Corporation | Herbicidal 3-(bicyclic nitrogen-containing heterocycle)-substituted-1-methyl-6-trifluoromethyluracils |
US5722402A (en) * | 1994-10-11 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structures |
US6690963B2 (en) * | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
US5690117A (en) | 1995-03-20 | 1997-11-25 | Gilbert; John W. | Ultrasonic-fiberoptic imaging ventricular catheter |
WO1996041312A1 (en) * | 1995-06-07 | 1996-12-19 | University Of Florida Research Foundation, Inc. | Automated method for digital image quantitation |
US5824005A (en) * | 1995-08-22 | 1998-10-20 | Board Of Regents, The University Of Texas System | Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias |
US5848972A (en) * | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
US5697377A (en) * | 1995-11-22 | 1997-12-16 | Medtronic, Inc. | Catheter mapping system and method |
DE19622078A1 (en) * | 1996-05-31 | 1997-12-04 | Siemens Ag | Active current localising appts. for heart |
US5871019A (en) * | 1996-09-23 | 1999-02-16 | Mayo Foundation For Medical Education And Research | Fast cardiac boundary imaging |
US5669382A (en) * | 1996-11-19 | 1997-09-23 | General Electric Company | System for measuring myocardium in cardiac images |
US6095976A (en) * | 1997-06-19 | 2000-08-01 | Medinol Ltd. | Method for enhancing an image derived from reflected ultrasound signals produced by an ultrasound transmitter and detector inserted in a bodily lumen |
US20040006268A1 (en) * | 1998-09-24 | 2004-01-08 | Super Dimension Ltd Was Filed In Parent Case | System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure |
US6364835B1 (en) | 1998-11-20 | 2002-04-02 | Acuson Corporation | Medical diagnostic ultrasound imaging methods for extended field of view |
US6522906B1 (en) | 1998-12-08 | 2003-02-18 | Intuitive Surgical, Inc. | Devices and methods for presenting and regulating auxiliary information on an image display of a telesurgical system to assist an operator in performing a surgical procedure |
US7343195B2 (en) * | 1999-05-18 | 2008-03-11 | Mediguide Ltd. | Method and apparatus for real time quantitative three-dimensional image reconstruction of a moving organ and intra-body navigation |
US6443894B1 (en) * | 1999-09-29 | 2002-09-03 | Acuson Corporation | Medical diagnostic ultrasound system and method for mapping surface data for three dimensional imaging |
US7366562B2 (en) | 2003-10-17 | 2008-04-29 | Medtronic Navigation, Inc. | Method and apparatus for surgical navigation |
US6650927B1 (en) | 2000-08-18 | 2003-11-18 | Biosense, Inc. | Rendering of diagnostic imaging data on a three-dimensional map |
US20030093067A1 (en) * | 2001-11-09 | 2003-05-15 | Scimed Life Systems, Inc. | Systems and methods for guiding catheters using registered images |
DE10210648A1 (en) | 2002-03-11 | 2003-10-02 | Siemens Ag | Medical 3-D imaging method for organ and catheter type instrument portrayal in which 2-D ultrasound images, the location and orientation of which are known, are combined in a reference coordinate system to form a 3-D image |
US7477763B2 (en) | 2002-06-18 | 2009-01-13 | Boston Scientific Scimed, Inc. | Computer generated representation of the imaging pattern of an imaging device |
US7270634B2 (en) | 2003-03-27 | 2007-09-18 | Koninklijke Philips Electronics N.V. | Guidance of invasive medical devices by high resolution three dimensional ultrasonic imaging |
WO2004086086A2 (en) | 2003-03-27 | 2004-10-07 | Koninklijke Philips Electronics N.V. | Guidance of invasive medical devices with combined three dimensional ultrasonic imaging system |
WO2004084737A1 (en) | 2003-03-27 | 2004-10-07 | Koninklijke Philips Electronics N.V. | Guidance of invasive medical devices by three dimensional ultrasonic imaging |
WO2005079492A2 (en) | 2004-02-17 | 2005-09-01 | Traxtal Technologies Inc. | Method and apparatus for registration, verification, and referencing of internal organs |
US7972298B2 (en) | 2004-03-05 | 2011-07-05 | Hansen Medical, Inc. | Robotic catheter system |
US8515527B2 (en) | 2004-10-13 | 2013-08-20 | General Electric Company | Method and apparatus for registering 3D models of anatomical regions of a heart and a tracking system with projection images of an interventional fluoroscopic system |
US7713210B2 (en) * | 2004-11-23 | 2010-05-11 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for localizing an ultrasound catheter |
-
1993
- 1993-09-23 CA CA002678625A patent/CA2678625A1/en active Pending
- 1993-09-23 AT AT93922724T patent/ATE160273T1/en active
- 1993-09-23 WO PCT/US1993/009015 patent/WO1994006349A1/en active IP Right Grant
- 1993-09-23 CA CA2447239A patent/CA2447239C/en not_active Expired - Lifetime
- 1993-09-23 JP JP50843194A patent/JP3581888B2/en not_active Expired - Fee Related
- 1993-09-23 CA CA2144973A patent/CA2144973C/en not_active Expired - Lifetime
- 1993-09-23 DE DE69315354T patent/DE69315354T2/en not_active Expired - Lifetime
- 1993-09-23 EP EP93922724A patent/EP0661948B1/en not_active Expired - Lifetime
-
2000
- 2000-06-07 US US09/589,407 patent/US6826420B1/en not_active Expired - Fee Related
- 2000-06-07 US US09/589,409 patent/US6826421B1/en not_active Expired - Fee Related
-
2003
- 2003-02-26 US US10/375,752 patent/US6978168B2/en not_active Expired - Fee Related
-
2004
- 2004-01-28 JP JP2004019295A patent/JP3876344B2/en not_active Expired - Lifetime
- 2004-12-03 US US11/003,207 patent/US7289843B2/en not_active Expired - Fee Related
-
2005
- 2005-11-03 US US11/265,137 patent/US20060084970A1/en not_active Abandoned
- 2005-11-03 US US11/265,140 patent/US20060058692A1/en not_active Abandoned
- 2005-11-03 US US11/265,142 patent/US8208998B2/en not_active Expired - Fee Related
- 2005-11-03 US US11/265,138 patent/US20060084971A1/en not_active Abandoned
- 2005-11-03 US US11/265,141 patent/US20060058693A1/en not_active Abandoned
- 2005-11-03 US US11/265,133 patent/US20060084884A1/en not_active Abandoned
- 2005-11-03 US US11/265,139 patent/US20060084972A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP3876344B2 (en) | 2007-01-31 |
US20050101874A1 (en) | 2005-05-12 |
JPH08501477A (en) | 1996-02-20 |
DE69315354D1 (en) | 1998-01-02 |
US20060058692A1 (en) | 2006-03-16 |
EP0661948B1 (en) | 1997-11-19 |
ATE160273T1 (en) | 1997-12-15 |
EP0661948A1 (en) | 1995-07-12 |
WO1994006349A1 (en) | 1994-03-31 |
CA2144973A1 (en) | 1994-03-31 |
US20060084972A1 (en) | 2006-04-20 |
CA2678625A1 (en) | 1994-03-31 |
US20060084971A1 (en) | 2006-04-20 |
US6978168B2 (en) | 2005-12-20 |
JP2004209262A (en) | 2004-07-29 |
US8208998B2 (en) | 2012-06-26 |
US20060058693A1 (en) | 2006-03-16 |
DE69315354T2 (en) | 1998-03-19 |
US6826421B1 (en) | 2004-11-30 |
US6826420B1 (en) | 2004-11-30 |
JP3581888B2 (en) | 2004-10-27 |
US20060052716A1 (en) | 2006-03-09 |
CA2447239A1 (en) | 1994-03-31 |
US7289843B2 (en) | 2007-10-30 |
US20060084970A1 (en) | 2006-04-20 |
US20060084884A1 (en) | 2006-04-20 |
US20030176799A1 (en) | 2003-09-18 |
CA2447239C (en) | 2010-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2144973C (en) | Endocardial mapping system | |
US7831288B1 (en) | Method for mapping potential distribution of a heart chamber | |
US6603996B1 (en) | Software for mapping potential distribution of a heart chamber | |
US7930012B2 (en) | Chamber location method | |
US5297549A (en) | Endocardial mapping system | |
CA2351041C (en) | Rapid mapping of electrical activity in the heart | |
AU782718B2 (en) | Catheter, method and apparatus for generating an electrical map of a chamber of the heart | |
US6647617B1 (en) | Method of construction an endocardial mapping catheter | |
KR20050020713A (en) | Method for transient event mapping in the heart | |
EP4122413A1 (en) | Accurate tissue proximity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |